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Abstract 
Splicing mainly occurs co-transcriptionally, suggesting that transcription and pre-
mRNA splicing could be synchronized. The nature of this phenomenon suggests that 
transcription elongation rate may influence splicing outcomes and, indeed, there is 
evidence for effects on alternative splicing in mammals. To elucidate potential effects 
of transcription rate on splicing efficiency and fidelity, splicing of nascent transcripts 
was investigated in fast and slow elongating RNA polymerase II (RNAPII) mutants in 
Saccharomyces cerevisiae. High kinetic resolution 4-thio Uracil labelling of nascent 
RNA reveals that fast RNAPII accumulates unspliced pre-mRNA that represents 
reduced co-transcriptional splicing. Conversely, low levels of unspliced pre-mRNA 
were detected in the slow mutant due to increased co-transcriptional splicing. The 
highly stable association of nascent transcripts with elongating RNAPII permits co-
transcriptional splicing to be measured by analysis of transcripts that co-purify with 
RNAPII. Measuring co-precipitation of the spliced mRNA and excised intron that are 
associated with RNAPII demonstrates that splicing is mostly co-transcriptional with 
the slow mutant, and the fast mutant reduces co-transcriptional splicing. How 
elongation rate affects splicing fidelity in budding yeast and whether faster and slower 
transcription have the opposite effect on splicing fidelity as might be predicted by the 
kinetic coupling model is an open question. Using deep RNA sequencing, splicing 
fidelity was determined in yeast transcription elongation mutants. Results show that 
both fast and slow transcription reduce splicing fidelity mainly in ribosomal protein 
coding transcripts. Analysis reveals that splicing fidelity depends largely on intron 
length, secondary structure and splice site score. These analyses also provide new 
insights regarding the effect of altering transcription rate on selection of transcription 
start sites. Together, these results indicate that optimal splicing efficiency and fidelity 
require finely-tuned transcription speed. 
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Lay summary 
In most human genes the information (or code) in the DNA sequence is interrupted by 
noncoding regions called introns. A process called transcription produces RNA, which 
is a copy of the DNA. The RNA has to be cut and then spliced back together to remove 
the introns and produce an uninterrupted code for a protein. Frequently, the RNA 
pieces are joined in different ways, giving rise to proteins with different properties 
(like deleting or replacing scenes in a film to change a story). Mistakes in splicing the 
RNA, which can be caused by genetic defects or disease, result in defective proteins. 
Transcription and splicing are therefore of critical importance for controlling protein 
production and these processes are thought to be co-regulated. There is evidence that 
speed of transcription is tuned over the genes whose splicing may be regulated. The 
aim of this study was to investigate the effect that changing transcription speed has on 
RNA splicing. Yeast was used as a model organism for this study because many 
powerful experimental techniques are available. As these processes are highly 
conserved between yeast and humans, my results can also provide important insights 
into RNA splicing in humans. My results show that if transcription is faster or slower 
than normal, the amount of efficiently spliced RNA decreases or increases, 
respectively. In addition, most of the RNAs produced with faster and slower 
elongation speed have splicing mistakes that can potentially affect protein production. 
Overall, these findings help us to better understand the interaction between 
transcription and splicing and also provide us new understanding about how some 
splicing mistakes can occur. 
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Chapter 1 Introduction 
1.1 Transcription 
Transcription is the first stage of gene expression and is performed by three different 
RNA polymerases (I, II or III). During this process, RNA polymerase reads the genetic 
code from DNA and synthesizes an RNA molecule. Protein coding RNAs are 
polymerised by RNA polymerase II (RNAPII) and exported to the cytoplasm for 
protein synthesis by the translation machinery. This flow of genetic information from 
DNA to protein is known as the central dogma of molecular biology1. RNAPII is also 
responsible for transcription of many noncoding RNAs including small nuclear RNAs 
and microRNAs2. RNAPI synthesises ribosomal RNAs (rRNA) and RNAPIII 
transcribes the 5s rRNA, tRNA, U6 small nuclear RNA and some other small RNAs3.  
1.1.1 Transcription by RNA polymerase II 
Transcription driven by RNAPII is a multistep controlled process that is divided into 
four major steps; initiation, promoter escape, elongation and termination. After 
assembling the RNAPII complex on the promoter region, initiation of transcription 
occurs with the help of general transcription factors. After synthesizing a small 
fragment of RNA, transcription complexes with successful initiation escape from the 
promoter region and enter the elongation phase. In highly expressed genes, several 
transcription complexes perform elongation simultaneously4. The transcription 
process is terminated after transcribing the target gene and the complex is 
disassembled from the DNA and recycled for further transcription cycles. Eukaryotic 
RNAPII is a large complex of proteins comprising 12 subunits (Rpb1-12). Three of 
these subunits Rpb4, Rpb7 and Rpb9 are unique to RNAPII and are not essential for 
the transcription process in yeast5. Rpb9 is essential for transcription in Drosophila6. 
The other 9 subunits are found in all three eukaryotic RNA polymerases. Rpb1, Rpb2, 
Rpb3 and Rpb11 are the core and conserved subunits that have a common structure 
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and function with the prokaryotic core RNA polymerase7. Rpb1 is the largest subunit 
that contains the carboxyl-terminal domain (CTD) and the trigger loop (TL).  
1.1.1.1 Carboxyl-terminal domain of RNAPII 
The carboxy-terminal domain (CTD) of the large subunit, Rpb1, is an essential and 
unique domain in RNAPII and is conserved from yeast to human. This domain is 
absent in the other two RNA polymerases; RNAPI and RNAPIII. In mammals, the 
CTD contains 52 tandem heptapeptide repeats (YSPTSPS) Tyr-Ser-Pro-Thr-Ser-Pro-
Ser8.  In yeast, the CTD is shorter, with only 26 heptapeptide repeats8. During the 
transcription cycle, the serine, threonine and tyrosine residues of the CTD undergo a 
series of controlled phosphorylation and dephosphorylation cycles that modulate 
transcription initiation, promoter escape, elongation, termination and multiple co-
transcriptional processes9–11. Additionally, peptidyl-prolyl bond isomerisation can 
occur at Pro3 and Pro6 by a prolyl isomerase and the threonine and the serine residues 
can be glycosylated10.  
The most studied modifications of the CTD are phosphorylation and 
dephosphorylation of the serine residues. During the transcription process, multiple 
kinases and phosphatases add and remove the phosphate groups from the CTD to 
modulate transcription and co-transcriptional events10. Ser2 (Ser2p) and Ser5 (Ser5p) 
phosphorylations are required for expression of all genes transcribed with RNAPII, 
whereas Ser7 (Ser7p) phosphorylation is required for expression of specific genes10. 
Ser5p and Ser2p are predominantly placed in promoter and 3’end of the genes 
respectively, although some studies detected Ser5p at the 3’end of some genes as 
well10.  Ser7p and Ser5p are enriched early during the transcription process but only 
Ser7p persists at high levels until transcription terminates12. The CTD modifications 
play crucial role in RNA biogenesis. For example, Ser7p is higher than Ser2p over  
non-coding genes and is required for 3’end processing of the small nuclear RNAs13. 
Ser5p is important for recruitment of the capping enzyme (guanylyl transferase) 
responsible for capping the 5’ end of RNA10. Ser2p is associated with the recruitment 
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of histone modification, elongation, splicing, transport, 3′ end RNA-processing 
factors. Ser5p and Ser2p are not mutually exclusive and the Ser5p-Ser2p double mark 
has been shown to facilitate the recruitment of Prp40 and U2AF659,14.     
The cycle of phosphorylation and dephosphorylation of the CTD is regulated 
by several enzymes (Figure 1.1). In yeast, Kin28 (human homologues Cdk7) a 
component of TFIIH factor, phosphorylates Ser515 while Ssu72 and Rtr1 have been 
characterized as Ser5p phosphatases 16. Phosphorylation of Ser2p and Ser7p is carried 
out by Ctk1 and Bur1 (homologues of Cdk9 and Cdk12 respectively in mammals,)10. 
However, Fcp1 dephosphorylates Ser2p17 while removal of the phosphate group from 
Ser7p18 is carried out by Ssu72. The order, timing and place of phosphorylation and 
dephosphorisation of the CTD is important for faithful gene expression, and 
deciphering of the CTD code is integral to better understanding of co-transcriptional 
RNA processes10,11.  
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Figure 1.1: The carboxyl-terminal domain phosphorylation pattern across yeast and human 
protein-coding genes relative to the transcription cycle. The kinases and phosphatases responsible 
for establishing these patterns are noted above and below, respectively. The symbol “?” indicates an 
enzyme suspected to have this function. Figure is from10. 
1.1.1.2 Tigger loop of RNAPII 
Trigger loop (TL) is a mobile domain of Rpb1 located in the catalytic centre of 
the RNA polymerase and is conserved in RNAPI, II, III and also in prokaryotic RNA 
polymerase19. TL directly interacts with the base-paired substrates through its 
evolutionarily conserved histidine residue (His1085 in S. cerevisiae, His936 in E. coli 
β′ and His1108 in human). The exact function of TL is yet to be understood but it is 
implicated in regulating substrate selection, translocation and catalysis20.  It is 
proposed that direct interaction between the TL and a NTP substrate matched with 
DNA template stabilize base-pairings at the 3’-end of the nascent RNA and regulate 
transcription fidelity19. The TL was also found to play a role in intrinsic cleavage of 
RNA and transcriptional pausing through rearrangements in the catalytic centre21. 
Mutations in TL can affect the dynamics of TL mobility and result in changes in 
transcription elongation rates both positively and negatively (Figure 1.2)20.  
Figure 1.2: S. cerevisiae Rpb1 trigger loop20.  Cartoon showing the nucleotide interacting region and 
the hinge regions. Mutations in the highlighted residues alter trigger loop properties and cause changes 
in transcription elongation rate. The yeast mutant rpb1-G1097D causes faster transcription while rpb1-





1.1.2 Transcription initiation 
The first step in transcription is transcription initiation, which starts with recognition 
of the promoter by the core protein recognition factors. The TATA box sequence in 
the promoter is then recognized by TATA binding protein (TBP), a component of the 
TFIID22. Only ~ 20% of yeast genes contain a TATA box sequence in their promoter 
and they are generally associated with stress response23. There are some differences in 
the factors involved in the recognition of promoters which contain or not TATA 
sequence, however, TFIID complex is functionally redundant at many promoters. 
Binding TBP to DNA induces a bend in the region23. After promoter recognition, the 
assembly of factors required for transcription initiation is facilitated by binding of the 
transcription activators upstream of the promoter and recruitment of chromatin 
remodelers. TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH are general transcription 
factors required for successful initiation complex formation. TFIIA and TFIIB 
stabilize TBP and TATA interaction and subsequently TFIIB recruits RNAPII and 
TFIIF to the initiation site22. TFIIF stabilizes TFIIB and stimulates transcription 
elongation. Assembly of TFIIE and TFIIH facilitate unwinding of the DNA in the 
promoter site and complete formation of the pre-initiation complex (PIC). Next, DNA 
is opened by ATP hydrolysis forming the 'transcription bubble' and RNA synthesis 
initiates. Phosphorylation of Ser5 and Ser7 by TFIIH (human Cdk7) and the departure 
of some transcription factors after transcribing a few nucleotides leads to promoter 
escape and entering the elongation phase24. 
1.1.3 Transcription elongation 
After successful initiation, RNAPII enters the early elongation phase and synthesizes 
the mRNA by elongating from 5’ to 3’. Before RNAPII enters the active elongation 
state, in higher eukaryotes RNAPII experiences a promoter proximal pausing that is 
mediated by negative elongation factor (NELF) and DRB sensitivity inducing factor 
(DSIF)25. This pausing is potentially involved in effective 5’capping of the RNA, 
synchronous activation, checkpoint for coupling elongation, some RNA processing 
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functions and recruitment of multiple regulatory signals26. Positive transcription 
elongation factor (P-TEFb), facilitates the release from pausing, displacing NELF by 
phosphorylation23. P-TEFb is one of the main regulators of transcription elongation 
and interacts with different proteins and RNA subunits. DSIF and P-TEFb have 
homologs in eukaryotes ranging from yeast to human, but yeast and Caenorhabditis 
elegans appear to lack NELF, suggesting that NELF regulatory function could be 
restricted to a subset of eukaryotes27. In yeast, Bur1 and Ctk1, which are components 
of P-TEFb, are responsible for Ser2 phosphorylation leading to productive elongation 
via changing the CTD phosphorylation pattern from Ser5/Ser7 to Ser2/Ser723. The 
processivity of transcription, stable association of RNAPII with the DNA, is regulated 
by multiple elongation factors such as Spt5 and TFIIS and histone chaperons like Spt6 
and Spt1623,25. RNAPII faces multiple barriers during the elongation phase and a 
productive elongation requires effective histone modifications, repositioning of the 
nucleosomes and chromatin remodelling. RNAPII can move a few nucleotides 
backwards, called back-tracking, which is implicated in several critical processes, 
including controlling transcription elongation, pausing, termination, fidelity, and 
genome instability28. Co-transcriptional RNA processing mechanisms can also affect 
elongation by RNAPII23,29.     
1.1.4 Transcription termination 
The final step of transcription is transcription termination that finishes transcription of 
the gene and prevents transcription read-through into the downstream gene. The 
release of protein coding RNA from transcription machinery is achieved with co-
transcriptional recruitment of the cleavage and polyadenylation factors to the 
termination processing signals at the 3′ untranslated region (UTR) of the nascent 
RNA30. Pcf11 binds to hyper-phosphorylated Ser2 CTD and after endonucleolytic 
cleavage of the RNA at the cleavage and polyadenylation site, poly(A) polymerase 
Pap1 adds a tail of poly A repeats to the 3’ end of the cleaved RNA31. Currently, two 
models explain the dissociation of the RNA from the polymerase. According to the 
torpedo model, Rat1, a nuclear 5' to 3' single-stranded RNA exonuclease, is then 
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recruited by the CTD-interacting protein Rtt103 and degrades the downstream portion 
of cleaved RNA and triggers dissociation of the elongation complex32. Alternatively, 
the allosteric model suggests that polyadenylation leads to loss of elongation factors 
and/or conformational changes in transcription, which stimulate transcription complex 
dissociation. After adding a tail, poly binding protein (PABP) binds to the Poly A and 
protects the RNA from degradation33. Alternative polyadenylation that mainly occurs 
in higher eukaryotes also play an important role in gene regulation34. Transcription 
termination of non-coding RNAs is facilitated by the Nrd1–Nab3–Sen1 (NNS) 
pathway in yeast and the cap-binding complex (CBC)–ARS2 pathway in humans32.  
1.2 Pre-mRNA splicing 
The primary RNA synthesized by transcription is called precursor messenger RNA 
(pre-mRNA). Forty years ago, Berget et al. discovered that pre-mRNA contained 
intervening sequences, called introns, which are flanked on either side by exon 
segments35. Splicing is the process of removing introns from pre-mRNAs and ligating 
adjacent exons to produce messenger RNA (mRNA). The process of splicing is 
catalysed by the spliceosome, a multi-megadalton ribonucleoprotein (RNP) complex.  
The splicing process is mainly conserved from yeast to human and this made yeast a 
model organism for studying splicing mechanisms. Less than 5% of S. cerevisiae genes 
(~300) contain an intron and splicing of most of these introns is required for viability36. 
Despite the low number of intron-containing genes in yeast, some of these genes are 
highly expressed, leading to production of approximately one third of the cellular 
protein coding transcripts. Although, across species the splicing mechanism is 




1.2.1 The mechanism of pre-mRNA splicing 
The spliceosome removes introns from pre-mRNAs by two consecutive trans-
esterification reactions36. The intron boundaries are defined by 5’ splice site (exon-
intron junction) and 3’ splice site (intron-exon junction). Within the intron, there are 
branch-point (BP) and polypyrimidine tract sequences that are required by the splicing 
mechanism. The first reaction is a nucleophilic attack of the 2’-OH group of the 
conserved adenosine in the branch point (BP) sequence to the phosphate of the guanine 
nucleotide at the 5' splice site (Figure 1.3). This makes an unusual 2'-5' phosphodiester 
bond between BP and 5’ splice site and exon-intron junction is cleaved. The products 
of this step are a lariat intron-exon2 intermediate and a free 3'-OH at the end of the 
cleaved 5’exon. Conformational rearrangement of the spliceosome components allows 
catalysis to proceed to the second trans-esterification reaction. In the second step, 
nucleophilic attack of the 3'-OH end of the released exon to the 3’ splice site cleaves 
the intron-exon junction and the two exons are joined. The intron is released as RNA 
a lariat structure and then de-branched by Drb1 and finally degraded. The spliceosome 
is then disassembled and recycled for further splicing reactions. 




1.2.2 Consensus sequences define the intron boundaries 
Consensus sequences determine pre-mRNA intron/exon boundaries. R/GUAUGU 
(where the symbol “/” denotes the cleavage site) is the consensus sequence for the 
5’SS in yeast that is complementary to the U1 snRNA 5’SS base pairing region. The 
first two nucleotides (/GU) are conserved and their mutations prevent splicing of the 
intron38. AG/ dinucleotide at the end of introns defines the 3’SS. The vast majority of 
introns in eukaryotic genes fit the canonical 5’SS/GU-AG/3’SS borders.  UACUAAC 
is the consensus BP sequence that base pairs with U2 snRNA. The last adenosine 
nucleotide is conserved across species and is required for the first trans-esterification 
reaction. The polypyrimidine tract is a U-rich sequence upstream of the 3’SS of the 
intron. The major class of introns with these consensus sequences are spliced with U2-
dependent spliceosomes. The U12-dependent spliceosome, which is absent in S. 
cerevisiae, mediates splicing of a minor class of introns that have non-canonical 
consensus sequences in higher eukaryotes39. In addition to these consensus sequences, 
there are numerous cis-acting regulatory elements that recruit trans-acting factors to 
enhance or suppress the splicing reaction.  
1.2.3 Spliceosome mediated splicing 
The core spliceosome is composed of 5 small nuclear RNAs designated as snRNAs 
(U1, U2, U4, U5, U6), and a range of distinct proteins that associate with the snRNAs 
to generate small nuclear ribonucleoprotein complexes (snRNP)36. Several snRNA-
pre-mRNA, protein-RNA and protein-protein interactions are required to catalyse the 
splicing reaction. Spliceosome assembly involves an ordered, stepwise assembly of 
snRNPs and other distinct proteins to the pre-mRNA40. Spliceosome assembly starts 
with recruitment of U1 snRNP to the 5’SS and initiating the commitment complex or 
early complex formation (Figure 1.4). Commitment complex formation also requires 
Bbp1 and Mud2 (human U2AF65) that recognize BP and nearby sequences, 
respectively41. Direct interaction of the U1 snRNP with CTD of RNAPII facilitates its 
recruitment to the 5’SS14. U1-5’SS interaction is ATP-independent and unstable, and 
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other auxiliary factors help its stability42. U2-snRNP is recruited onto the 3’SS in a co-
transcriptional manner and this interaction is facilitated by U2 auxiliary factors 
(U2AFs) and some other proteins. ATP hydrolysis by Prp5 and Sub2 (DExD-box 
helicases) facilitate recognition of the BP and interaction of the U2-snRNP with U1-
snRNP to form pre-spliceosome complex (A complex). Interaction between U1-
snRNP and U2-snRNP across the intron is called intron definition. In higher 
eukaryotes where introns are often much longer than exons, splice sites are recognized 
via U1-U2 snRNP interaction across the exons, forming an exon definition complex43. 
Subsequently, rearrangements of this complex brings the 5’SS, 3’SS and BP of the 
intron in close proximity. After formation of complex A, U4/U6.U5 tri-snRNP, a 1.5-
megadalton pre-assembled tri-snRNP complex is recruited, to form B complex, in a 
reaction mediated by Prp28 (DExD/H-box RNA helicase). Subsequently, complex B 
is catalytically activated (complex B*) through a series of conformational 
rearrangements and with the help of multiple RNA helicases including Brr2, Snu114 
(a U5-snRNP component) and Prp2. During the activation of B complex, Brr2 unwinds 
the U4-U6 snRNA duplexes, result in forming U2–U6 snRNA structure44.  At this step, 
U1 and U4 snRNPs are released from the complex. Complex B* performs the first 
catalytic step and nucleates the formation of complex C. Products of the first catalytic 
step are the excised and free 5’ exon and the intron–exon  lariat intermediate, which 
are associated with complex C. Following several ATP-dependent rearrangements, 
complex C carries out the second catalytic step that generates a lariat intron and joins 
the exons together. Function of complex C is mediated by Prp8, Prp16, Prp18 and 
Slu7. After the second step has occurred, the ATPase activity of Prp22 releases the 
spliced product from the spliceosome. Upon completion of the splicing reaction, 
several RNA helicases including Brr2, Snu114, Prp22 and Prp43 are responsible for 
promoting spliceosome disassembly to recycle its components for additional rounds 
of splicing42. Recent in vitro splicing studies have revealed that all splicing steps are 
revisable, even both catalytic steps, however, it is still unclear whether splicing can be 
reversed in vivo42,45. 
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Figure 1.4: Step-wise assembly of the spliceosome and catalytic steps of splicing42. RNAPII helps 
co-transcriptional assembly of splicing factors. 
1.2.4 Alternative splicing 
Before sequencing of the human genome, it was believed that there are 40000 up to 
100000 protein-coding genes in a single human cell. However, later extensive genome 
sequencing studies reduced this estimation to as few as 19000 protein coding genes46. 
Conversely, thanks to next generation transcriptome sequencing, the number of 
transcripts that undergo alternative splicing increased from 50% at 2002 to almost 
100% to date37. Recently, by using in silico methods, researchers estimated that 19000 
human genes can produce more than 200,000 protein coding transcripts46,47. This 
means that one gene can produce multiple isoforms of transcripts, a function that is 
achieved with alternative splicing of pre-mRNA. In mammals, nearly all pre-mRNAs 
contain more than two exons, which facilities differential alternative splicing37. There 
are five major modes of alternative splicing; exon skipping, mutually exclusive exons, 
alternative 5’SS, alternative 3’SS and intron retention (Figure 1.5). A combination of 
splice sites strength, presences of cis and trans acting elements, chromatin 
12 
 
environment, RNA structure, RNA transcription and degradation can determine the 
outcome of pre-mRNA alternative splicing. In yeast, only few genes have more than 
two exons and alternatives splicing is not a common event.  
Figure 1.5:  Major alternative splicing events in the metazoan transcriptome. Blue boxes indicate 
constitutive exons, while brown boxes indicate alternative spliced exons. 
1.2.5 Co-transcriptional splicing 
Based on in vitro studies, it was believed that splicing occurs after transcription and 
when 5’ capping and 3’ end processing of the RNA is completed. However, mounting 
evidence during the last two decades have changed this picture to a view that the 
majority of splicing events are catalysed before transcription termination; meaning that 
splicing is happening co-transcriptionally. The first striking evidence of splicing pre-
mRNA during RNAPII transcription was shown 29 years ago by 'Miller spread' 
electron micrograph on Drosophila melanogaster embryonic gene (Figure 1.6a)48. 
Later, multiple labs demonstrated co-transcriptional recruitment of splicing factors to 
the nascent transcript49. In 2011, after more than two decades, next generation cellular 
total RNA sequencing (NGS) has revealed the same picture by showing the widespread 
co-transcriptional splicing in human liver and brain cells50. This study has revealed a 
5’-3’ slope in the read coverage, especially on the long introns, which supports the 
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model that splicing is carried out immediately after transcription of an intron. This 
'saw-tooth' pattern is repeated over each intron due to co-transcriptional splicing of 
intron immediately after its transcription (figure 1.6b). Additionally, studying 
chromatin associated transcripts in yeast, drosophila and human cell lines further 
supported the prevalence of co-transcriptional splicing51–53. Capturing the native 
elongating transcripts with RNAPII immunoprecipitation followed by sequencing 
(NET-seq) further confirmed the extensive co-transcriptional splicing in yeast with 
high resolution. More recently, the innovative single-molecule intron tracking (SMIT) 
approach showed that spliceosome assembly and splicing can take place immediately 
following intron synthesis by RNAPII54. While splicing can also occur post-
transcriptionally, splicing during transcription can add more layers of RNA processing 
regulation tools by allowing mutual interactions between splicing and chromatin, 
transcription and other RNA processing mechanisms55. For example, it has been 
shown that co-transcriptional recruitment of splicing factors to nascent RNA prevents 
R-loop formation and thereby enhances genomic stability, and also it can prevent RNA 
from degradation to allow proper maturation56,57. In fact, computational modelling of 
splicing and transcription has suggested that co-transcriptional splicing is more 
efficient than post-transcriptional splicing58. As a result of co-transcriptional splicing, 
recruitment of splicing factors by RNAPII and transcription elongation rate can 
influence splicing outcome by two mechanism, referred to as the recruitment coupling 
and the kinetic coupling models59. These two coupling models are not mutually 




Figure 1.6: (a) Electron micrograph of a Drosophila melanogaster embryonic gene showing co-
transcriptional splicing (left) and its interpretation (right)48,60. The dark blobs show transcription 
complexes. Grey and white arrows show introns that are spliced out co-transcriptionally. The black 
arrow indicates the direction of transcription along the DNA template. (b) Pattern for AUTS2 (top) 
viewed in the UCSC Genome Browser. Model for co-transcriptional splicing (bottom).  
1.2.6 “The recruitment model” of co-transcriptional splicing 
The recruitment coupling model involves spliceosome components and splicing factor 
recruitment to splicing sites by the transcription machinery (Figure 1.7)59. The CTD is 
the unique feature of RNAPII that acts as a ‘landing pad’ for co-transcriptional 
recruitment of the capping, splicing and 3’ end processing factors on nascent RNA60. 
In yeast, Prp40, a U1 snRNP component, was shown to bind to the phosphorylated 
CTD and in human PSF (PTB-associated splicing factor) and p54/NRB are splicing 
factors that physically bind to CTD14.  Additionally, it has been shown that physical 
interaction of U2AF65–Prp19 complex with CTD promotes splicing activation14. A 
mutant RNAPII (Ser2A) where Ser2 phosphorylation was inhibited, reduced 
recruitment of U2AF65 and U2 snRNP, and as a consequence negatively affected co-
transcriptional splicing61. This suggests that CTD Ser2p is critical for recruitment of 
U2AF65 to ensure efficient co-transcriptional splicing. Strong support for the 
recruitment model was obtained by a study in human cell lines showing CTD 
dependent inhibitory action of serine/arginine-rich (SR) protein SRSF3 (SRp20) in 
inclusion of fibronectin cassette exon 33 (E33)59. Some reports suggest that co-
transcriptional splicing factor recruitment is not exclusively through CTD of RNAPII 
and splicing factors can also be recruited on nascent RNA via interaction with other 
transcription factors. An interesting example is PGC-1, a transcriptional coactivator 
that has certain motifs characteristic of splicing factors, which binds to the promoter 
and enhances exon 25 (E25) inclusion in fibronectin mRNA in a CTD-independent 
manner62. Transcription mediator complex may also help to recruit splicing factors at 
the promoter, or interact with nascent RNA splicing factors via its MED23 subunit. 
This subunit partially colocalizes with hnRNP L which is an alternative splicing 
regulator and some U1/U2 snRNPs associated factors55. It also has been shown that 
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MED23 can regulate most of the alternative splicing events that are modulated with 
hnRNP L55.  
Figure 1.7: Schematic representation of the recruitment coupling model, adapted from63. CTD of 
RNAPII helps recruitment of splicing factors on pre-mRNA. Green shapes show different splicing 
factors.  
1.2.7 “The kinetic model” of co-transcriptional splicing 
This model proposes that RNAPII elongation rate can affect splicing outcome (Figure 
1.8). The first evidence for the kinetic model was proposed 29 years ago by Eperon et 
al, where they suggested that transcription elongation rate can influence splicing 
through affecting nascent RNA structure64. Today there is a plethora of evidence 
showing that transcription elongation rate can affect splicing outcome both in yeast 
and metazoans29,55,59,65. For example, binding of DNA-binding protein CTCF to the 
downstream intron of exon 5 (E5) in CD45 enhances E5 inclusion by acting as a road 
block for RNAPII66. DNA methylation of the intron inhibits CTCF binding and 
reverses the effect on E5. More direct evidences for the kinetic model were observed 
by using RNAPII elongation mutants or by using drugs that affect transcription 
elongation rate. The first evidence of kinetic coupling in budding yeast is illustrated 
by Howe et al with enhanced second exon inclusion of DYN2 transcripts in a slow 
mutant RNAPII strain or when cells were treated with transcription inhibitors67. 
Similarly, inclusion of the fibronectin EDI exon was promoted in human cultured 
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cells that were expressing a slow RNAPII68. These observations have provided direct 
evidence for the effect of tuning transcription elongation rate on alternative splicing. 
More recent studies have shown that a slower elongation could also increase exon 
exclusion rate. For example, Dujardin et al reported that slower elongation causes 
skipping of the exon 9 in a CFTR minigene due to effective recruitment of ETR-3, a 
negative splicing factor to the 3’ss of the exon69. Likewise, RNA sequencing of human 
cell lines with fast and slow RNAPII also showed changes in inclusion and exclusion 
rates of thousands of exons70.  
Kinetic coupling also was observed globally, showing RNAPII pausing within 
the terminal exons of intron-containing transcripts51. It is suggested that RNAPII 
pausing over terminal exons can provide sufficient time for splicing to occur before 
transcription termination51. Similarly, high resolution kinetic assays with a reporter 
gene has revealed splicing-dependent RNAPII pausing in yeast71. This suggests that a 
splicing-dependent transcriptional checkpoint might exist to promote co-
transcriptional splicing of the upstream intron. Consistent with these observations, it 
was shown that sequences required for the effect of TCERG1, a factor that associates 
with the Bcl-x pre-mRNA alternative splicing in drosophila, coincide with a putative 
polymerase pause site72. Recently, NET-seq has also revealed RNAPII pausing at 
intron-exon junctions and reported increased RNAPII density over exons that coincide 
with U1 snRNP occupancy73. These observations were explained as a model in which 
U1 snRNP is rapidly recruited to RNAPII pause sites through physical interaction with 
Ser5P CTD to promote co-transcriptional splicing. Single-molecule intron tracking 
(SMIT), which measures progression of splicing relative to RNAPII position along the 
genes genome-wide showed that the fast RNAPII transcribed significantly further than 
normal RNAPII when splicing occurred54,74. SMIT results further supported that 




Figure 1.8: Schematic representation of the kinetic coupling model60. Slow transcription opens the 
window of opportunity for upstream events and enhances exon inclusion. Fast elongation enhances exon 
exclusion by allowing downstream splice sites to compete with upstream splice sites.   
Chromatin and DNA sequence features are also involved in modulating 
transcription elongation rate over intron-containing transcripts. The analysis of 
genome-wide datasets has shown that RNAPII elongates faster in low GC and low-
complexity DNA sequences75–77. Exons are GC reach and have higher nucleosome 
occupancy; features that are associated with slow elongation rate77.  Additionally, 
some specific post-translational histone methylation signatures that are associated with 
reduced RNAPII elongation rate are enriched over exons. These features might be 
involved in reducing transcription elongation rate to facilitate splice site recognition 
and co-transcriptional splicing.  
Overall, kinetic coupling suggests that transcription determines the temporal 
window of opportunity for splicing of the upstream intron or exon and selecting or 
rejecting the upstream splice site before competing with a downstream event. Based 
on the kinetic model of coupling, slow transcription expands the window of 
opportunity for co-transcriptional splicing and faster transcription shortens this 
window and reduces co-transcriptional splicing of an upstream event (Figure 1.8). 
Potentially, competing co-transcriptional splicing events that could be affected due to 
shortening or stretching of the window of opportunity by elongation rate could be 
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recognition of splice sites, RNA binding sites, RNA folding, the time required for 
spliceosome assembly and effective recruitment of splicing regulatory factors. 
Coordination of these events with transcription elongation rate can determine the 
outcome of splicing. Genome-wide studies showed that not all splicing events are 
kinetically coupled to transcription elongation rate and there might be specific features 
or conditions that make a particular splicing event sensitive to transcription 
elongation78. 
1.2.8 Splicing affects transcription 
Coupling of transcription and splicing is not unidirectional from transcription to 
splicing, in fact this interaction is reciprocal and splicing activity can also regulate 
transcription. Studies with transgenic mice has shown that presence of an intron in a 
gene body promotes gene expression and transcription efficiency79–81. Comparing 
intron-containing and intronless genes also has revealed that presence of a promoter 
proximal splice site enhances transcription81. These observations suggest splicing-
dependent transcription regulation. It has also shown that some splicing factors directly 
interact with the transcription complex and regulate its function. For example, it was 
shown that the snRNPs interact with TAT-SF1, and stimulate RNAPII elongation rate 
on an intronless gene though association with P-TEFb, a transcription elongation 
factor.  TAT-SF1–U snRNPs interaction also stimulates in vitro splicing and therefore 
this interaction is suggested as a potential coupling factor that facilitates reciprocal 
activation of transcription and splicing82. U1 snRNA associates with TFIIH, a general 
transcription factor, and regulates transcription in addition to its role in splicing83. 
SC35, a splicing factor, attenuates transcriptional elongation in a gene-specific 
manner, modulating P-TEFb recruitment and CTD Ser2 phosphorylation84. In yeast, it 
was shown that mutating splice sites on a reporter gene abolishes transcriptional 
pausing at the 3’ splice site71. Further investigations with prp5-1 mutant, which blocks 
pre-spliceosome formation, has shown that RNAPII with high Ser5p CTD accumulates 
over the intron85. This extended pause was shown to be dependent on Cus2, a yeast 
homolog of human TAT-SF1. Mammalian NET-seq has also revealed that treatment 
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of cells with a splicing inhibitor pladienolide B (Pla-B), which interferes with U2 
snRNP function, reduces RNAPII pausing over downstream exons86.  
Although these studies explain the mutual cross talks between splicing and 
transcription, still more investigation needs to be performed to determine how these 
links are established and regulated, which are the key coupling factors and what is the 
advantage of coupling for the cells.   
1.2.9 Splicing proofreading and fidelity 
Splicing fidelity is defined as the mechanism by which the spliceosome distinguishes 
optimal vs suboptimal splice sites. DExD/H-box ATPases play pivotal roles in 
proofreading steps and fidelity mechanisms. Two non-mutually exclusive models are 
proposed for splicing fidelity mechanisms87. In both models, DExD/H-box ATPases 
function as timers and/or sensors of authenticity. In the timer model, the speed of a 
substrate as it proceeds through the proofreading check points relative to rate of 
ATPase activity of proofreading factors will either promote or antagonize the substrate 
usage. Generally, if the substrate proceeds slower than ATPase activity, it will be 
rejected. For example, Prp5, Prp16 and Prp22 antagonize substrates that are slow 
probably due to having suboptimal introns that potentially slow down splicing88–90. In 
the sensor model, DExD/H-box ATPases reject a suboptimal substrate faster than an 
optimal substrate. In this model, ATPase activity either is regulated to specifically 
antagonize suboptimal substrate or ATPase activity will destabilize the weak substrate-
spliceosome interactions. It has been shown that some of the ATPases actually 
destabilize less stable substrates and they also negatively or positively are regulated to 
proofread the splicing substrate87.  
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Figure 1.9: Function of spliceosomal DExD/H-box ATPases in proofreading substrates during 
different stages of splicing cycle87. Small blue circles represent snRNPs, large blue oval  
represents catalytically active spliceosome. 
As splicing assembly occurs in stepwise fashion, there are proofreading factors 
that quality control splicing sequentially during the splicing process (Figure 1.9). 
Following U2 snRNP recruitment to pre-mRNA, ATP hydrolyses by Prp5 rejects 
splicing of introns with slow U2 snRNP – suboptimal branch point interactions and 
stabilizes optimal U2 snRNP –branch point interactions88,91,92. After formation of a 
catalytically active spliceosome (complex B*), Prp16 activity rejects substrates with 
suboptimal branch sites by antagonizing 5′ splice site cleavage leading to accumulation 
of intermediate complexes that are detected by Prp43 and eventually discarded93,93,94. 
Optimal branch point sequences lead to efficient cleavage of 5′ splice site followed by 
Prp16-mediated conformational changes that facilitate spliceosome to proceed to exon 
ligation step95. Prior to exon ligation, Prp22 activity rejects suboptimal slow substrates 
that are detected by Prp43 and eventually discarded90,96. Prp22 promotes the release of 
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the mRNA from the spliceosome after successful exon ligation of optimal 
substrates97,98. Eventually, the spliceosome is disassembled by Prp43 into its 
components and excised intron is released99,100.   
1.2.10 RNA degradation 
In all biological systems RNA turnover plays three important roles101. First, 
differential degradation of RNA determines the half-life of a given RNA in response 
to cellular demands and physiological stresses. Secondly, errors can occur during all 
RNA maturation steps including transcription, splicing or 3′-end processing but they 
are largely detected by RNA surveillance systems and degraded. Thirdly, RNA 
degradation removes the RNA processing intermediates and by-products including 
excised introns or the RNA rejected from processing complexes. There are three 
different classes of RNA degradation enzymes: endonucleases, 5’-3’ exonucleases and 
3’-5’ exonucleases. Xrn1 and Rat1 (Xrn2) are cytoplasmic and nuclear 5’-3’ 
exonucleases, respectively101. Exosome, which is a conserved cytoplasmic and nuclear 
multi-protein complex, has both 3′–5′ exoribonuclease and endonuclease activity 
carried out by its Dis3/Rrp44 subunit. Nuclear exosome has an additional 3'-5' 
exonuclease called Rrp6, which is not absolutely essential for yeast cell viability102. 
The exosome requires additional co-factors such as the TRAMP complex that marks 
faulty mRNAs101. It was shown that Dis3 plays a prominent role in degradation of 
intron-containing transcripts103. Expressing a mutant Dis3 enzyme in yeast cells (dis3 
exo−) increased accumulation of the intron-containing transcripts in splicing proficient 
cells103. This suggests that RNA degradation competes with splicing in processing the 
pre-mRNAs. What is the functional significance of this competition is not clear. 
Recently, it has been shown that Gbp2 and Hrb1 are important pre-mRNA splicing 
surveillance factors that are recruited co-transcriptionally to pre-mRNA and mark 
faulty pre-mRNAs for degradation104,105. These proteins recruit nuclear export receptor 
Mex67 to the correct mRNAs upon completion of splicing to allow a quality controlled 
nuclear export. How these factors recognise whether a pre-mRNA is faulty or authentic 
is unknown.  
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Nonsense-mediated mRNA decay (NMD) is an additional surveillance 
mechanism coupled with translation that eliminates mRNAs that contain premature 
translation-termination codons (PTCs)106. Unspliced pre-mRNAs that are leaked to the 
cytoplasm can also be targeted by NMD because these pre-mRNAs more likely contain 
PTCs107. Expression of some of normal transcripts that do not have PTCs were also 
shown to be regulated by NMD factors108,109. Aberrant alternative splicing can 
potentially introduce PTCs in mRNA that are detected and removed by NMD; a 
mechanism that is often referred to as alternative splicing coupled to NMD110,111. 
Genome-wide studies in budding yeast as well as in other multicellular organisms with 
inactivated NMD pathway showed accumulation of the non-productive alternatively 
spliced transcripts that contain PTCs111–113. Collectively, these studies indicated that 
PTCs containing unspliced pre-mRNA or aberrantly spliced transcripts that are 
exported to the cytoplasm are generally targeted and degraded by NMD in eukaryotes. 
Three core components of the NMD pathway are the proteins encoded by the 
UPF1, UPF2 and UPF3 genes. These proteins are evolutionarily conserved across 
eukaryotes and knocking down these factors inactivates the NMD pathway leading to 
accumulate mRNAs containing PTCs and truncated proteins114.  Upf1 is an RNA 
helicase that has ATPase activity and is the central regulator of the NMD pathway115. 
UPF1 is not essential for the viability of yeast or C. elegans; however, it is essential 
in Drosophila, zebrafish, mouse and human cells116. Some studies in human cells have 
reported that Upf1 and other NMD components are present in the nucleus and play 
additional roles possibly unrelated to NMD, in telomere maintenance, cell cycle 
progression and DNA replication116. To date, there is no evidence of Upf1 function in 
the nucleus in budding yeast.  
1.2.11 Yeast, as a model organism for co-transcriptional 
splicing 
The budding yeast S. cerevisiae has a small genome, short genes and also a simple 
constitutive splicing compared to other higher eukaryotes. Although only ~5% of 
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genes encode transcripts that undergo splicing, the splicing mechanism and most of 
the core splicing factors are largely conserved with other eukaryotes. Similar to 
splicing and other essential cellular processes, the transcription process is also 
conserved and therefore makes yeast a promising model organism for studying co-
transcriptional splicing. Additionally, yeast cells are inexpensive to work with, easy to 
grow in the laboratory and amenable to genetic manipulations.  
1.3 Aims of this study 
The aims of this project were to study the consequences of altering transcription 
elongation rate on splicing efficiency and fidelity: 
 Testing the effect of fast and slow transcription elongation rates on 
splicing efficiency of cellular steady state and nascent RNA 
 Testing co-transcriptional splicing by immunoprecipitation of RNAPII 
and assessing association of the spliced mRNA and excised lariat with 
elongating transcription complex 
 Investigating the effect of fast and slow transcription elongation rates 
on exon skipping and transcription start site selection in yeast 
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Chapter 2 Materials and Methods 
2.1 Sources of enzymes and reagents  
Unless stated otherwise enzymes used in this study were purchased from New England 
BioLabs, Roche, Qiagen, PeqLab, Promega, Invitrogen and Sigma-Aldrich. Common 
reagents were mainly purchased from Fisher Scientific, New England BioLabs, 
Formedium and Invitrogen.  
2.2 Growth Media and Common Buffers 
Bacterial and yeast media were supplied by the university central facility. Self-
prepared liquid media were autoclaved and cooled to room temperature before use. 
For solid media, 2% (W/V) agar was added to liquid media before autoclaving. When 
required, antibiotics were added to the media after autoclaving when media was 
relatively cool and stored at 4°C. All the buffers were autoclaved prior to use and 
stored at room temperature. Non-autoclavable buffers were filter sterilized using 
Nalgen Rapid-Flow 0.2 μm filter units. A list of all the media and reagents used is 




Yeast extract  1% (w/v)  
Bacto-peptone  2% (w/v)  
Glucose  2% (w/v)  
Adenine sulfate  0.003% (w/v)  
YMM 
Yeast nitrogen base without 
amino acids  
0.67% (w/v)  
Glucose  2% (w/v)  
Drop-out media 
YMM  -  




manufacturer’s instructions  
Bacterial media 
LB 
Bacto-tryptone  1% (w/v)  
Yeast extract  0.5% (w/v)  
NaCl  0.5% (w/v)  
SOC 
Bacto-tryptone  2% (w/v)  
Yeast extract  0.5% (w/v)  
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NaCl  0.06% (w/v)  
KCl  0.02% (w/v)  
MgCl2  0.1%(w/v)  
MgSO4  0.12% (w/v)  
Glucose  0.4% (w/v)  
Commonly used buffers 
50x TAE 
Tris base  2 M  
Acetic acid  5.71 (v/v)  
EDTA  50 mM  
10X TE 
Tris-HCl  100 mM  
EDTA ph 8.0  10 mM  
20X MOPS SDS-Page 
MOPS 1M 
Tris-base 1M 
SDS 20% (w/v) 
EDTA 20 mM 
A.E 
NaAc pH5.3  50 mM  
EDTA  10 mM  
Yeast transformation mix 
40% PEG3350 (w/v)  240 μl  
1M LiAc  36 μl  
Heat denatured salmon 
sperm DNA  
50 μg  
Yeast genomic DNA 
extraction 
dH2O  4.24 ml  
Triton-X-100  100 μl  
10% SDS  500 μl  
5M NaCl  100 μl  
1M Tris-HCl pH 8.0  50 μl  
0.5M EDTA pH 8.0  10 μl  
Total volume  5 ml  
4tU labelled RNA extraction buffers 
10x NaTMg 
(DEPC treated) 
Tris Cl pH7.0 10 mM 
NaCl 200 mM 
MgCl2 25 mM 
1x NaSTPMg 
(Stored up to 5 hrs) 
NaTMg  1x 
NaPi pH6.8 100 mM 
SDS (This added last) 0.1% 
H2O (This added first)  
Native elongating transcript extraction buffers 
Lysis buffer, 10× 
(Stored up to 1 year) 
HEPES, pH 7.4 200 mM 
KOAc 1100 mM 
Triton X-100 5%  
Tween 20 1%  
Lysis buffer, 1× 
(Stored up to 5 hrs on ice) 
10× lysis buffer stock  1× 





SUPERase.In 50 U/ml 
Wash buffer 
(Stored up to 5 hrs on ice) 
10× lysis buffer  1× 
SUPERase.In 50 U/ml 
EDTA 1 mM 
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TEV cleavage buffer 
20X ProTEV Buffer 15 µl  
SUPERase.IN 3  µl 
0.1 M DTT 3 µl 
DPEC water 279 µl 
Proteinase digestion mix 
Proteinase K  0.2mg/µl  
SDS 0.5%  
TNE (Tris, Nacl, EDTA) 1x 
 
2.3 Antibiotics 
Common Name  Company Name  Final concentration 
(μg/ml)  
Ampicillin (E.coli)  Life technologies  100  
Hygromycin B  Life technologies  400 
Yeast Kanamycin (G148)  Life technologies  400 
 
2.4 Antibodies 
Protein Beads Antibodies Company Name 
Rpb3 TAP tag IgG Sepharose Rabbit Anti-Tap-Tag  GE Healthcare 
 
2.5 Yeast strains 
Strain  Genotype  Source 
JBY115 
MATa ura3-52 his3∆200 leu2∆1 or ∆0 trp1∆63 met15∆0 lys2-128∂ 
gal10∆56 rpb1∆::CLONATMX RPB3:: TAP::KlacTRP1  pCK859 RPB1 
T69 corrected* CEN LEU2 
C. Kaplan 
et al 2012  
JBY122 
MATa ura3-52 his3∆200 leu2∆1 or ∆0 trp1h∆63 met15∆0 lys2-128∂ 
gal10∆56 rpb1∆::CLONATMX RPB3:: TAP::KlacTRP1  pCK876 rpb1 
G1097D T69 corrected CEN LEU2 
C. Kaplan 
et al 2012  
JBY123 
MATa ura3-52 his3∆200 leu2∆1 or ∆0 trp1∆63 met15∆0 lys2-128∂ 
gal10∆56 rpb1∆::CLONATMX RPB3:: TAP::KlacTRP1  pCK870 rpb1 
H1085Y T69 corrected CEN LEU2 
C. Kaplan 
et al 2012  
JBY133 
MATa ura3-52 his3∆200 leu2∆1 or ∆0 trp1∆63 met15∆0 lys2-128∂ 
gal10∆56 rpb1∆::CLONATMX RPB3:: TAP::KlacTRP1 ∆upf1::HPH  




MATa ura3-52 his3∆200 leu2∆1 or ∆0 trp1h∆63 met15∆0 lys2-128∂ 
gal10∆56 rpb1∆::CLONATMX RPB3:: TAP::KlacTRP1 ∆upf1::HPH  




MATa ura3-52 his3∆200 leu2∆1 or ∆0 trp1∆63 met15∆0 lys2-128∂ 
gal10∆56 rpb1∆::CLONATMX RPB3:: TAP::KlacTRP1 ∆upf1::HPH  






MATa ura3-52 his3∆200 leu2∆1 or ∆0 trp1∆63 met15∆0 lys2-128∂ 
gal10∆56 rpb1∆::CLONATMX RPB3:: TAP::KlacTRP1  pCK859 RPB1 




MATa ura3-52 his3∆200 leu2∆1 or ∆0 trp1h∆63 met15∆0 lys2-128∂ 
gal10∆56 rpb1∆::CLONATMX RPB3:: TAP::KlacTRP1  pCK876 rpb1 




MATa KY691, ura3-52 his3∆200 leu2∆1 or ∆0 trp1∆63 met15∆0 lys2-
128∂ gal10∆56 rpb1∆::CLONATMX RPB3:: TAP::KlacTRP1  pCK870 




MATa ura3-52 his3∆200 leu2∆1 or ∆0 trp1∆63 met15∆0 lys2-128∂ 
gal10∆56 rpb1∆::CLONATMX RPB3:: TAP::KlacTRP1  pCK960 rpb1 
E1103G T69 corrected CEN LEU2 
C. Kaplan 
et al 2012 
JBY132 
MATa ura3-52 his3∆200 leu2∆1 or ∆0 trp1∆63 met15∆0 lys2-128∂ 
gal10∆56 rpb1∆::CLONATMX RPB3:: TAP::KlacTRP1 ∆upf1::HPH 
pCK960 rpb1 E1103G T69 corrected CEN LEU2 
This 
study 
* Kaplan et al1 detected a polymorphism in RPB1 plasmid encoding isoleucine at position 
69 instead of threonine. This substitution was corrected (T69 corrected) before generating 
WT and mutant strains.  
 
2.6 Plasmids 
Strain  Genotype  Source 




Yeast Uracil permease gene FUI1 cloned into pRS416 





Oligonucleotides were purchased from Sigma-Aldrich. 











Oligonucleotides used for RT-qPCR to determine splicing status 
ALG9_F  TAAGCTGGCATGTGCTGCATTC  































ACT1 pre-mRNA F  TACATCAGCTTTTAGATTTTTCACGCTT 
ACT1 pre-mRNA R ATTCTGGTATGTTCTAGCGCTTGCACCATC 
ACT1 mRNA F  TCGAAAATTTACTGAATTAACAATGGA  
ACT1 mRNA R  GCAAAACCGGCTTTACACAT  
ACT1 Lariat F  AGGGGCTTGAAATTTGGAAAAA  
ACT1 Lariat R  GCAAGCGCTAGAACATACATAGTACA  
ACT1 3’SS F  TTGCTTCATTCTTTTTGTTGCT 
ACT1 3’SS R  GCAAAACCGGCTTTACACAT 
RPL39 pre-mRNA F  AACACAGATAGATCAACATGGCTGTATGT  
RPL39 pre-mRNA R  GGTGGTAAGGTCATTTAGATGGATGTG  
RPL39 mRNA R  GTGGCAATGGTCTGTTTTGCTTC  
RPL39 mRNA F  AGATCAACATGGCTGCTCAAAAGTC  
RPL39 3’SS F  CGTATGTGCACGATATGTTTCCCTTT 
RPL39 3’SS R  GTGGCAATGGTCTGTTTTGCTTC 
RPL28 Lariat F GAGCGCAATTATGAAAAAGAGTTACCA 
RPL28 Lariat R TTCCAAATGGAACTACATACATAGTAAAACAG 
RPL28 pre-mRNA F TCCAGATTCACTAAGACTAGAAAGCACAGA 
RPL28 pre-mRNA R TTGGTTCTTTCATTCCCTCTTCCA 
RPL28 mRNA F TCCAGATTCACTAAGACTAGAAAGCACAGA 
RPL28 mRNA R TGACCACCGGCCATACCTCT 
COF1 pre-mRNA F ATCTGGGTATGCTAAATTTCATTTGTACTCC 
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COF1 pre-mRNA R AGCGAGATAAAACAGCATCATGTCAA 
COF1 mRNA F TCTGGTGTTGCTGTTGCTGATG 
COF1 mRNA R CAACGATTTCGGTTTTAGCATCG 
UBC13 pre-mRNA F AGAAATGGCATCATTACCCAAGAGAA 
UBC13 pre-mRNA R CGGCTCAGACGAAAACGTCA 
UBC13 mRNA F AGAAATGGCATCATTACCCAAGAGAA 
UBC13 mRNA R TTGCGTTTTCTGCCCTAGTAGTTTG 
HRB1 pre-mRNA F CAGGATATGTCTGATCAAGAACGAGGT 
HRB1 pre-mRNA R CATTTTACAAACTTTTCTTCACCTCCCTTA 
HRB1 mRNA F AAGTTAACAGGATATGTCTGATCAAGAACGA 
HRB1 mRNA R AGACCAATAAGTCATTGCGTTTCAAAG 
ECM33 pre-mRNA F  AGTGCCTCCGCTCTAGCTGGT 
ECM33 pre-mRNA R CGAGATTTGTGAGGAAAGAGGCAAA 
ECM33 mRNA F  GCCTCCGCTCTAGCTGCTAACTC  
ECM33 mRNA R  TTGAGCAGTAGCAGTGGCAGAAGT 
ECM33 Lariat F  CCTGTCATAGGATTAGGGCGAGT 
ECM33 Lariat R  GTATGTACACATTCTCCTTTATAGTATTCCCG 
RPS13 pre-mRNA F TCGTATGCACAGTGCCGTATGTT 
RPS13 pre-mRNA R TGATTTAGCGAACTATTCAATGCAACTTT 
RPS13 mRNA F TCGTATGCACAGTGCCGGTAA 
RPS13 mRNA R AGGACAACTTGAACCAAGCTGGAG 
RPS13 3’SS F  TCCAATTCCACTAAATATTACTTTAAACAGGGTA 
RPS13 3’SS R  CTTGAACCAAGCTGGAGCATTTCT 
 
2.8 Strain maintenance and growth 
2.8.1 Yeast culture and preservation 
Yeast liquid cultures were grown at 30°C in flasks containing YPDA medium with 
shaking at 180 rpm unless stated otherwise. Yeast strains containing auxotrophic 
plasmids were grown in YMM supplemented with the appropriate drop out powders 
in order to maintain the selection pressure. In the case of yeast strains containing 
antibiotic resistance genes integrated in the genome the suitable amount of antibiotic 
was added to the growth media. Yeast strains were preserved on solid medium for up 
to two weeks at 4°C. For long term storage, 15% (v/v) sterile glycerol was added to 1 
ml of yeast culture and stored in cryogenic tubes at -80°C.  
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2.8.2 Growth analysis  
For growth analysis, saturated overnight cultures were diluted to 0.1 OD600 and grown 
until the log phase to 0.6. OD600. The exponential phase cultures were again diluted 
back to 0.1 OD600 and 100 µl of the culture pipetted into a sterile flat-bottomed 96 well 
plate and growth curve assayed using Sunrise Absorbance Microplate Reader (Tecan 
Trading AG). Plate reader was set to shake at 180 rpm and detect OD600 measurement 
every 15 minutes for 18 hours. Each growth curve experiment was carried out at least 
in three technical and biological replicates.  
2.8.3 Spotting Assay 
Saturated overnight yeast cultures were diluted to 0.1 OD600 and then allowed to grow 
until 0.6 OD600 was reached (this correspond to at least two doubling times). Four 
tenfold serial dilutions ranging from 0.2 to 0.0002 OD600 were made from the growing 
cultures and 250 µl were pipetted to a sterile flat-bottomed 96 well plate. These cells 
were then transferred and spotted into an appropriate sterile solid medium using pin 
multi-blot replicators. Plates were then incubated at 30°C and photographed after 2-3 
days.   
2.9 E.coli and Plasmids 
2.9.1 Transformation of competent E. coli with pre-existing 
plasmids 
E. coli competent cells for transformation were purchased from Agilent and stored at 
-80°C. A 50 µl aliquot of the competent cells was thaw on ice and split into two tubes 
to make a sample for plasmid transformation and a negative control. 50 ng of the 
plasmid was added and gently mixed with the cells. Sample was incubated on ice for 
2 minutes then heat shocked at 42°C for 45 seconds. Cells were placed on ice for 2 
minutes after heat shock. Next, 300 μl of SOC medium was added to the sample and 
39 
 
then incubated at 37°C for 1 hour with shaking. Subsequently, cells were spread on 
LB plate supplemented with the selective antibiotic ampicillin and incubated at 37°C.   
2.9.2 Isolation of plasmid DNA from E. coli 
Purification of plasmid DNA from E. coli was carried out using New England BioLabs 
plasmid DNA mini-prep kit according to manufacturer’s instructions. 
2.10 Yeast transformation 
Yeast transformation was carried out using high efficiency lithium acetate method of 
Gietz and Schiestl2. A single yeast colony from a freshly streaked plate was inoculated 
into 10 ml liquid medium and then grown overnight to saturation. From the overnight 
culture, 50 ml of 0.1 OD600 of diluted cells were let to grow until log phase was reached 
(OD600 of 0.8). Cells were then pelleted by centrifugation for 2 minutes at 3500 rpm 
and washed twice with 10 ml of sterile distilled water. Pelleted cells were resuspended 
in 500 µl of 100 mM LiAc and transferred to a 1.5 ml Eppendorf tube. 100 µl of the 
cells were added to prepared transformation mix containing desired PCR amplified 
fragment or plasmid, single strand DNA from Salmon sperm and 36 µl of LiAc 1M. 
The mix was vortexed vigorously for 30 seconds and incubated at 30°C on a rotating 
wheel for 15 minutes and heat shocked at 42°C in a water bath for 30 minutes. Sample 
was then spun and cells resuspended in 100 µl sterile distilled water and spread on a 
YPDA plate and incubated overnight at 30°C. The following day, yeast were replica 
plated on a plate containing the appropriate selective medium and incubated at 30°C 
for 2-3 days. For each transformation performed, transformation mix with no PCR 
fragment or plasmid was used as a negative control.  
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2.11 Yeast DNA methods 
2.11.1 Extraction of yeast genomic DNA  
A single colony of yeast was inoculated in 10 ml of YPDA and grown overnight. 1.5 
ml of the saturated culture was transferred to a centrifuge tube and the cells were 
pelleted for 5 minutes at 3500 rpm. The pellet was washed twice with distilled water. 
The cell pellet was resuspended in 200 μl of genomic DNA extraction buffer, 200 μl 
of phenol-chloroform (5:1 vv) and 300 μl zirconia beads (Thistle Scientific) were 
added to the sample. Sample was mechanically ground by a bench top vortex for 5 
minutes to disrupt the cell wall. After centrifugation at 140000 rpm for 5 minutes, the 
supernatant was transferred to a new tube. DNA precipitation was carried out by 
adding 600 μl of 100% ethanol. The sample was incubated at -20°C for at least 1 hour 
and spun at maximum speed (13k rpm) for 5 minutes at 4°C. The supernatant was 
discarded and pelleted sample was washed twice with 70% ethanol and resuspended 
in 100 μl of water.  
2.11.2 Standard PCR methods 
PCR was performed to verify the correct genomic integration of the transformants. 
Genomic DNA was extracted from single colonies as described in 2.11.1 and 50 ng of 
genomic DNA was used for performing PCR in a 25 μl reaction mix as stated at the 
following table. PCR programme was adjusted according to the specific annealing 
temperature of the primers used and the specific DNA fragment size of interest.  
PCR reaction mix 
Forward primer (100μM) 0.125 μl 
Reverser primer (100μM) 0.125 μl 
Taq Pol 0.5 μl 
Taq Pol Buffer (10X) 2.5 μl 
DMSO 1 μl 
dNTP (10mM) 1 μl 
Genomic DNA 50-500ng 




2.11.3 Agarose gel electrophoresis 
Agarose gel electrophoresis was performed to visualize the correct fragment size 
amplified by PCR. Agarose was weighed and dissolved in 1xTAE buffer by heating to 
make 1% gel DNA staining dye SYBR Safe was also added to the mixture. Tracking 
dye 0.5 μl (Bromophenol blue 1 %) was added to 5 μl of PCR reaction and samples 
were loaded in the gel placed in a tank submerged in 1xTAE buffer. Electrophoresis 
was performed at 120 V and then the gel was scanned under UV light using Syngene 
gel doc to visualize the DNA fragments  
2.11.4 Isolation of plasmid DNA from yeast 
In order to verify if the correct centromeric plasmid was contained in the appropriate 
yeast strains, plasmids were extracted from yeast and purified using Zymoprep yeast 
plasmid mini-prep kit according to the manufacturer’s instructions. Finally, the correct 
sequence validated by Sanger sequencing. 
2.11.5 DNA Sanger sequencing 
The correct sequence of the plasmid was verified by Sanger sequencing. First, region 
of interest from plasmid was amplified by appropriate primers using BigDye® 
Terminator v3.1 cycle sequencing kit according to the manufacturer’s instructions. 
Samples were then sent to the Edinburgh Genomics to undergo Sanger sequencing. 
SeqMan Pro tool from DNASTAR software package was used to process the 




2.12 Yeast RNA methods 
2.12.1 Rapid RNA sampling 
A yeast colony was grown overnight in the appropriate liquid medium. Cells were then 
diluted to 0.1 OD600 in 50 ml medium and allowed to grow at least 2-3 doubling times 
(OD600 of 0.6-0.8). 10 ml of the culture were snap frozen by pipetting into a 15 ml 
falcon centrifuge tube containing chilled methanol placed in dry ice. The sample was 
then centrifuged immediately at 3000 g for 2 minutes at 4°C and total RNA was 
extracted from the pelleted cells.  
2.12.2 Isolation of total RNA from yeast 
For extracting total RNA, cells were resuspended in 400 µl AE buffer and transferred 
into a 2 ml screw cap tube. 40 µl SDS 10%, 800 µl phenol (pH=4.3) and 200 µl of 
zirconia beads (Thistle Scientific) were also added to the tube. The cells were lysed 
using a mini beads-beater (Biospec Products) for 2 minutes for three rounds. Samples 
were left on ice for two minutes between each lysing step. Next, samples were placed 
on dry ice for 5 minutes until they were solidified and centrifuged at 14000 rpm for 5 
minutes at room temperature. The supernatant was transferred into a new tube 
containing 600 µl phenol:CHCl3 5:1, vortexed vigorously and spun for 3 minutes at 
140000 rpm. The supernatant was transferred to a new tube containing 600 µl CHCl3, 
vortexed vigorously and spun for 3 minutes at maximum speed. The supernatant was 
transferred to a new tube and RNA was precipitated by adding 300 µl of 10 M LiCl 
and incubated at -20°C for at least 30 minutes. Precipitated samples were spun for 10 
minutes at 4°C and pelleted RNA was washed with 70% ethanol. RNA was finally 
resuspended in RNase free water or 1xTE and stored at -70°C.  
2.12.3 Isolation of 4-thio-uracil labelled RNA  
Strains used for this method were previously transformed with the expression plasmid 
pRS416-FUI1 in order to enhance the uptake of labelled uracil from culture. Cultures 
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from single colonies were grown in synthetic medium lacking uracil and leucine amino 
acids to 0.8 OD600. 100 µM of 4-thiouracil were added into 600 ml of culture shaking 
at 180 rpm. After 1, 1.5, 2.5, 5 and 10 minutes of labelling, 100 ml of the culture was 
snap frozen by pouring the culture in a beaker containing 50 ml chilled methanol sitting 
on dry ice. Each sample was centrifuged immediately at 3000 g for 3 min at 4 °C, the 
pellet was then washed twice with cold water and total RNA was extracted as described 
in previous paragraph. RNA was dissolved in 300 µl RNase free TE with a 
thermomixer at 65°C and then by pipetting up and down. The samples were 
biotinylated with 0.22 mg EZ-link HPDP Biotin in dark at 65°C for 15 minutes. Zeba 
desalting columns (Thermo Fisher Scientific) were used for desalting samples after 
biotinylation according to manufacturer’s instructions. The samples were then 
precipitated with 1/3 volumes of 10 M LiCl and incubation at -20°C for 30 minutes. 
RNA was pelleted by centrifugation for 5 min and 14000 rpm and then washed twice 
with 80% ethanol to remove any remaining biotin and LiCl. 200 µl from the sample 
with lowest concentration of RNA was used for newly synthesised RNA purification. 
The same amount of RNA was used for all the other samples and the volume was 
equalised to 200μl with water.  
Subsequently, 25 µl 10x NaTMg, 25 µl 1M NaPi pH6.8 and 2.5µl 10% SDS 
were added to each sample and mixed thoroughly. Throughout the following 
procedure, samples were kept at room temperature to avoid precipitation of SDS. 50 
µl of magnetic streptavidin beads were added to a new low retention 1.5 ml tube. 
Samples were placed on a magnetic rack to allow beads to settle on the tube wall and 
the fluid was removed by aspiration. Tubes were removed from the magnet and beads 
washed with 200 µl of NaSTPMg and vortexed until the pellet of beads was well 
resuspended. Tubes were spun at 1000 g for 30 seconds, placed on the magnetic rack 
to allow beads to settle by the magnet and the fluid was removed with aspiration. Beads 
were then blocked using 200 µl NaSTPMg, 10 µl glycogen and 2.5 µl 5 mg/ml tRNA 
and then placed on a rotating wheel at room temperature for 20 minutes. Beads were 
then washed as described before.  
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Next, beads were added to the RNA samples and incubated at room 
temperature rotating for 30 minutes. The supernatant was then removed and the beads 
were washed as before. For eluting the RNA off the beads 100 µl of freshly made 0.7 
M β-mercaptoethanol (βME) was added to the sample followed by vortexing and a 
brief spin to allow the beads to settle. Tubes were then placed on the magnetic rack 
and the supernatant was collected and transferred into a fresh 0.5ml low binding 
centrifuge tubes. The RNA samples were then precipitated with 2.5x volumes (280 µl) 
of ethanol at -20°C for 1 hour to overnight. The precipitated RNA was washed twice 
with 70% ethanol and dissolved in 10 µl of DEPC treated TE with RNase inhibitor. 
RNA quality and yield was measured by using an Agilent 2100 Bioanalyzer RNA 
Nano-Chip according to manufacturer’s instructions.  
2.13 Native elongating transcript purification  
Isolation of native elongating transcript was carried out according to a protocol 
published by Churchman and Weissman3 with little modifications. First, 
microfiltration apparatus containing a nitrocellulose filter membrane (0.45-μm, 90-
mm diameter from Whatman) was set up and connected to a vacuum. 1 litre of yeast 
log phase growing culture was poured gradually into the filter apparatus. Filtered yeast 
cells were scraped off from the filter membrane with a pre-chilled metal spatula and 
transferred into a 50 ml conical tube containing liquid nitrogen sitting on dry ice. After 
liquid nitrogen vaporized, frozen cells were stored in -80°C.  
Cell disruption was achieved by using a mixer mill (SPEX 6780), this system 
minimizes protein degradation by using a completely chilled apparatus. Liquid 
nitrogen was used to chill both mixer mill chamber and the metal ball used for 
grinding. Frozen yeast culture was ground 5 rounds for 3 min at 15 Hz with 2 minutes 
cooling between each round. Ground cells were scraped off from the chamber with a 
pre-chilled spatula and transferred to a 5 ml tube sitting in liquid nitrogen. Ground 
cells were stored at -80°C.  
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For immunoprecipitation, 0.5 ml Protein A Sepharose beads were used for each 
sample. Beads were washed twice by adding 10 ml of 1× lysis buffer to the slurry and 
supernatant was removed by centrifugation at 4°C for 2 minutes at 1000g. The washed 
beads were left on ice until ready to use. 1g of ground yeast was resuspended in 5 ml 
ice-cold 1× lysis buffer by pipetting up and down. 660 μl (660 units) of RNase-free 
DNase I (Promega) was added to the sample, mixed gently by inverting the tube for 
few times and incubated on ice for 20 minutes. Next, digested lysate was centrifuged 
at 20000 g, 4°C for 10 minutes. 20 μl of the supernatant was transferred to a new tube 
containing 20 μl 2×SDS buffer and set aside for immunoblotting to verify pull down 
efficiency. The remaining supernatant was added to the washed beads and incubated 
for 180 minutes at 4°C rotating. Subsequently, samples were spun for 2 minutes at 
1000g, 4°C. 20μl of supernatant was kept as control of the unbound fraction and 20 μl 
of 2×SDS buffer were added to the liquid. The excess supernatant was then discarded. 
The beads slurry was then washed four times with 10 ml of wash buffer, resuspended 
thoroughly by inverting the tube and placed on a rotator for 2 minutes at 4°C. Samples 
were then spun for 2 minutes at 1000 × g, 4◦C and supernatant was discarded. Next, 
beads were resuspended in 1 ml wash buffer and transferred to a low retention 1.5ml 
tube, spun for 2 minutes at 1000g, 4◦C and supernatant was removed.  
TAP-tagged RNAPII was eluted from beads by adding 300 μl TEV cleavage 
buffer and 5 μl of ProTEV protease (Promega). TEV digestion was perfomed at 18°C 
for 90 minutes with shaking at 180 rpm. The sample was then transferred to a Promega 
spin column and eluate was collected in a 2 ml tube by centrifugation. Beads were 
resuspended by adding 300 μl of water and mixed by pipetting up and down on the 
column. The column was centrifuged and the second eluate was collected and added 
to the first elute to obtain a final volume of 600 μl. The sample was then transferred to 
a new 1.5ml tube and digested with 100 μl proteinase K for 30 minutes at 37°C with 




2.14.1 Reverse transcription for splicing status 
After quality control of RNA with Nanodrop or Bioanalyser, RNA sample was treated 
with RNase free DNase I enzyme prior to reverse transcription. For DNase I treatment, 
desired amount of RNA was taken and volume of sample adjusted to 8 μl with RNase 
free water in a PCR tube. Subsequently, 1 μl 10x DNase I buffer, 0.9 μl DNase I 
enzyme and 0.1 μl RNase inhibitor were added to the sample and incubated at 37°C 
for 30 minutes. Next, DNase I enzyme was inactivated by heating for 10 minutes at 
75°C. For reverse transcription, 2.5 μl of the desired reverse primer (3μM) was added 
to the sample, and then heated for 3 minutes at 75°C and immediately chilled on slushy 
ice to allow primer annealing. From this sample, which had total volume of 12.5 μl, 5 
μl was taken for RT and another 5 μl taken as negative non-RT control. 5 μl of the RT 
master mix was then added to each sample and incubated at 55°C for 1-2 hours. The 
RT master mix was prepared with 2 μl reverse transcription buffer (5X), 0.75 μl 10mM 
dNTPs, 0.25 μl RNAse inhibitor, 1.7 μl H2O, and 0.3 μl reverse transcriptase enzyme 
per sample. For the non-RT control, water was added instead of the reverse 
transcriptase enzyme. Prior to qPCR analysis, cDNA sample was diluted 20 times with 
water.  
2.14.2 Quantitative real-time PCR for splicing status 
qPCR was performed with Roche LightCycler 480 II instrument according to 
manufacturer’s instructions and using the cycling illustrated in the following table. 
qPCR reaction was composed of 4 μl cDNA from 1:20 diluted RT reaction, 4 μl SYBR 
green from Agilent, 1 μl of 3 μM forward and reverse primers mix and 1 μl of H2O to 
obtain a final volume of 10 μl. The non-RT samples also were subject to qPCR as 
negative controls. qPCR was always carried out in three technical replicates to control 




Step 1: 94°C 2 min  
Step 2: 94°C 10 sec 
Step 3: 60°C 10 sec 
Step 4: 72°C 15 sec 
Step 5: Go to step 2 for total of 40 times 
Step 6: 95°C 10 sec 
Step 7: 60°C 10 sec 
Step 8: Ramp to 94°C 30sec.  
 
2.14.3 Analysis of qPCR output 
Relative abundance of PCR products were measured relative to different controls 
depending on the type of normalization required (relative to control genes ALG9 or 
SCR1, exon 2, RNA from wild type, etc.) by following equation: 
Relative abundance=2-(ΔCt) 
Where Ct = the threshold cycle 
ΔCt = Cttest – Ctcontrol 
 
2.15 Western blot  
Protein samples were run on pre-cast gradient gels 4-12% NuPAGE Bis-Tris. Gel was 
placed in Invitrogen gel tank and filled with 1x NuPAGE MOPS SDS (Invitrgen) 
running buffer. Electrophoresis was performed at 170 voltage until the sample dye 
reached to the bottom of the gel.   
Gel was disassembled from tank and proteins resolved in the gel were 
transferred to a nitrocellulose membrane (0.2 µm pore size) with iBlot western blotting 
system (Thermo Fisher Scientific) according to manufacturer’s instructions. After 
transfer, membrane was blocked with 5% skimmed milk in 1xPBS for 1 hour or 
overnight at 4°C with gentle shaking. Membrane was washed with wash buffer (1xPBS 
+ 0.1% Tween 20) three times for 10 minutes and immersed in 5% skimmed milk 
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containing recommended amount of the primary antibody for 1 hour at room 
temperature. Membrane was then washed as before and immersed in 5% skimmed 
milk containing recommended amount of the secondary antibody for 1 hour at room 
temperature. Membrane was then washed as before and proteins were detected with 
LI-COR Odyssey Scanner according to manufacturer’s instructions.       
2.16  Next-generation sequencing 
Total RNA was extracted from log phase growing culture in YPDA as described before 
and quality controlled by Agilent 2100 Bioanalyzer RNA Nano-Chip. RNA was then 
shipped in a box containing dry ice to the Beijing Genomics Institute (BGI) for library 
preparation and sequencing on Illumina HiSeq 4000. Strand‐specific, 150 bp paired‐
end deep sequencing was performed in two independent biological replicates for each 
strain (wild type, fast and slow). BGI treated the samples with DNase I and removed 
rRNA prior to strand specific library preparation using NEBNext® Ultra™ Directional 
RNA Library Prep Kit for Illumina according to manufactures instructions. After 
removing rRNA from the samples, total RNA was fragmented and first strand cDNA 
synthesis was performed with random primers. After performing the second strand 
cDNA synthesis, double-stranded cDNA was purified using Agencourt AMPure XP 
beads. Next, after end repair of the cDNA library, adaptor ligation was performed with 
optional NEBNext adaptor, followed by purifying the ligation reaction using AMPure 
XP Beads. PCR enrichment of the adaptor ligated DNA was performed according to 
manufactures instructions and the PCR reaction was purified using Agencourt AMPure 
XP beads. Library quality and quantity were assessed with a combination of qPCR and 
Bioanalyser. Three samples were loaded on each lane.           
2.16.1 Read mapping and counting    
BGI has performed initial quality controls and removed sequencing adapters and 
finally provided raw sequencing reads. Raw sequencing reads were then quality 
controlled using FastQC4 tool. STAR aligner5, was used for aligning the reads to the 
49 
 
yeast reference genome (sacCer3) using yeast GTF file (version R64-1-1.75) from 
ENSEMBL. STAR is a splice-aware RNA sequencing reads aligner and is widely 
recommended for its mapping accuracy and speed6. The following analysis were 
carried out on the Linux server (bifx-rta) provided by Wellcome Trust Centre 
Laboratory (COIL), University of Edinburgh.  
2.16.1.1 Creating genome index 
This code was used to create indexes from yeast genome that is required for STAR to 
run. Using or not using GTF file for building the genome index does not affect 
recognition of the novel sites.  
STAR --runMode genomeGenerate --runThreadN 15 --genomeDir /path-to-genome-directory/ --
genomeFastaFiles saCcer3.fa --sjdbGTFfile Saccharomyces_cerevisiae.R64-1-1.75.gtf   
2.16.1.2 Read alignment 
This code was used to map the reads to genome. Important output files were a junction 
file containing information about all detected junctions and their coverage, and a SAM 
file containing sequence alignment information. 
STAR --runThreadN 15 --genomeDir /path-to-genome-directory/ --readFilesIn 
forward_reads.fq reverse_reads.fq --sjdbGTFfile Saccharomyces_cerevisiae.R64-1-1.75.gtf   
2.16.2 Quantifying pre-mRNA fractions  
In order to quantify pre-mRNA fractions, the counts for specific read classes, e.g. 
boundary and junction reads were obtained by using the dice-count function from the 
DICEseq package7. Among these classes, reads that only belong to pre-mRNA are 
boundary and intron reads, while reads that only belong to mature mRNA are junction 
reads. Pre-mRNA fraction was defined by this equation (pre-mRNA reads) / (pre-
mRNA reads + mRNA reads).   
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2.16.3 Estimation of splicing error frequency (SEF) for 
novel alternative splicing events 
Alternative splicing events or novel splicing events were defined as splicing events 
that are within intron containing transcripts and are not annotated in Saccharomyces 
annotation file from ENSEMBL (version R64-1-1.75). Events supported with less than 
five unique reads were filtered out as they could come from sequencing or mapping 
errors. To calculate the frequency of each alternative splicing event within a gene, we 
used the following equation: 
 
𝑆𝐸𝐹 =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑟𝑒𝑎𝑑𝑠 𝑡ℎ𝑎𝑡 𝑎𝑙𝑖𝑔𝑛 𝑡𝑜 𝑡ℎ𝑒 𝑛𝑜𝑣𝑒𝑙 𝑠𝑝𝑙𝑖𝑐𝑒 𝑗𝑢𝑛𝑐𝑡𝑖𝑜𝑛
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑟𝑒𝑎𝑑𝑠 𝑡ℎ𝑎𝑡 𝑎𝑙𝑖𝑔𝑛 𝑡𝑜 𝑡ℎ𝑒 𝑎𝑛𝑛𝑜𝑡𝑎𝑡𝑒𝑑 𝑠𝑝𝑙𝑖𝑐𝑒 𝑗𝑢𝑛𝑐𝑡𝑖𝑜𝑛
 
Average of SEF score from biological replicates was used for calculating the 
p-value between SEF score of WT and mutants by fisher’s exact test. 
2.16.4 Estimation of splicing error frequency (SEF) for 
cryptic introns in intron-less transcripts 
Cryptic introns splicing events were defined as splicing events that are within intron-
less transcripts and are not annotated in S.cerevisiae annotation file from ENSEMBL 
(version R64-1-1.75). Events supported with less than five unique reads were filtered 
out and the frequency of each splicing event was obtained from the following equation:  
𝑆𝐸𝐹 =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑟𝑒𝑎𝑑𝑠 𝑡ℎ𝑎𝑡 𝑎𝑙𝑖𝑔𝑛 𝑡𝑜 𝑡ℎ𝑒 𝑐𝑟𝑦𝑝𝑡𝑖𝑐 𝑠𝑝𝑙𝑖𝑐𝑒 𝑗𝑢𝑛𝑐𝑡𝑖𝑜𝑛 𝑜𝑓 𝑡ℎ𝑒 𝑡𝑟𝑎𝑛𝑠𝑐𝑟𝑖𝑝𝑡
𝑅𝑃𝐾𝑀 𝑜𝑓 𝑡ℎ𝑒 𝑡𝑟𝑎𝑛𝑠𝑐𝑟𝑖𝑝𝑡
 
2.16.5 Sequence features and prediction of SEF 
To predict splicing error from sequence, the following features were considered as 
predictors: intron length, Delta G for intron, 5’SS score, 3’SS score and frequency of 
84 short sequences (1 to 3mers) from both annotated intron and novel intron. 5′SS and 
51 
 
3′SS scores were obtained as described8. The Delta G is a free energy score for RNA 
secondary structure, which is predicted by mfold v3.6 
(http://unafold.rna.albany.edu/?q=mfold). All these features were fetched with 
pyseqlib (https://github.com/huangyh09/pyseqlib). In total, 176 features were used to 
predict the SEF scores for novel splicing events. Based on these features, a random 
forest regression model was trained to predict the SEF score at log2 scale, and 3-fold 
cross-validation was used to evaluate the prediction performance. 3.1.1 Analysis of 
sequence features and prediction of SEF was carried out in collaboration with Yuanhua 
Huang (School of Informatics, the University of Edinburgh). 
2.16.6 Estimation of TSS and PAS  
In order to measure the transcript start site (TSS) and polyadenylation site (PAS), the 
reads that were partially mapped to the 5’end and the 3’end of coding sequence were 
fetched. Namely, part of such read is outside to the gene body. Given these partially 
mapped reads, the average distance between 5’ end of the reads and +1bp of the coding 
sequence was used to estimate the TSS (figure 2.1). TSS estimation by this strategy 
does not precisely map the location of TSS and might be estimated shorter due to bias 
introduced by the reads with shorter 5’ overhang (shorter distance) from CDS. To 
correct for this, the reads that do not reach to the estimated TSS, 5% of the original 
reads with shortest 5’end distance from coding sequence were removed. In fact, he 
average distribution of TSS estimated via this method agrees with previous studies9. 
Similarly, this strategy was applied to estimate PAS based on distribution of 3’end of 
the reads. The program used here is available in DICEseq v0.2.57 by following 
command line: dice-count -a anno_file -s sam_file -o out_file --partial --TSSmethod 
mean. Analysis of sequence features and prediction of SEF was carried out in 
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Chapter 3 Studying co-transcriptional splicing 
of newly synthesized RNA  
3.1 Acknowledgement 
RNAPII elongation mutants were a gift from Craig D. Kaplan1.  
3.2 Introduction 
There is extensive evidence that in both metazoans and budding yeast the process of 
splicing occurs as soon as the intron is transcribed and before transcription termination, 
i.e. co-transcriptionally2–4. How coupling is established and maintained between 
splicing and transcription is poorly understood. According to one model, referred to as 
the “kinetic coupling” model, variations in RNAPII elongation rate can alter the time 
available, or the “window of opportunity” for splicing factors to select alternative 
splice sites as they emerge from the RNAPII exit channel5–10. Consistent with this 
model, it was shown that RNAPII elongation rate is tuned by different elongation 
factors and other barriers like chromatin structure, which thereby impact splicing 
decisions5–7. Additionally, elongation rate over a gene can change multiple folds 
during different phases of the yeast cell cycle11. Probably, kinetic coupling 
mechanisms need to be able to adjust to fluctuations in elongation rate.  
Several approaches have been designed to provide insights into co-
transcriptional splicing kinetics. One way is crosslinking of the RNAPII to the DNA 
and immunoprecipitation of RNAPII elements bound to DNA followed by qPCR or 
sequencing of the isolated DNA fragments3,12,13. Due to presence of RNAPII in close 
proximity of the DNA, examining DNA fragments can provide an estimation of 
RNAPII coordinates on the RNA. However, this approach has limited spatial 
resolution and is affected by antibody specificity and also does not reveal whether 
RNAPII is actively engaged in transcription14. In human cells, deep sequencing of 
cellular total RNA has revealed saw-tooth profiles in read counts indicating ongoing 
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transcription and co-transcriptional splicing immediately after transcription of 3’SS4. 
This pattern is more obvious over the transcripts with long introns. Nuclear run-on 
strategy is based on the inhibition of RNAPII on the transcription initiation sites with 
chemical transcription inhibitors and capturing the nascent RNA from isolated nuclei 
after washing away the inhibitor and releasing of halted RNAPII15,16. This approach is 
used for global studying of co-transcriptional processes and mapping RNAPII 
positions in actively transcribed genes in yeast and mammalian cells16,17. Run-on assay 
requires extensive manipulation and isolation of the nuclei and effective re-initiation 
of transcription. Global co-transcriptional splicing in yeast was detected by isolating 
chromatin-associated RNA through chromatin fractionation and high-density tiling 
microarray analysis18. RNA extracted with chromatin fractionation does not always 
represent nascent RNA and also artefactual RNA interactions can occur during the 
fractionation procedure19. Native elongating transcript sequencing (NET-seq) is a 
breakthrough method that is used for pulling down RNAPII-nascent RNA complex 
and sequencing 3’ends of the nascent RNA14. NET-seq does not require crosslinking 
and is able to map the position of the RNAPII on the RNA at nucleotide resolution. 
This method was used recently to study co-transcriptional splicing and RNAPII 
pausing in yeast and mammalian cells20,21. Antibodies that recognize specific 
phosphorylated forms of RNAPII or antibodies against transcription initiation, 
elongation or termination factors, make NET-seq a powerful tool for studying 
transcripts associated with different stages of active transcription21,22. Efficiency of 
NET-seq depends on the specificity of the antibody and proper isolation of RNAPII-
RNA complexes along with reducing artefactual RNA interactions. The most recent 
tool is the SMIT assay introduced by the Neugebauer lab2. SMIT determines RNAPII 
position with selecting genes of interest by PCR with a forward primer in exon 1 and 
reverse primer at RNAPII position (3’end). This approach is able to measure co-
transcriptional splicing kinetics by determining position of the RNAPII when splicing 
occur. SMIT requires effective primer designing for a limited set of the genes that have 
long enough first exon or 5’UTR and additionally, SMIT could potentially 
overestimate the extent and speed of splicing23.  
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Recently, kinetic labelling of RNA with 4-thiouracil (4tU) has proved to be an 
effective way to enrich for the newly synthesized RNA and used to measure the RNA 
synthesis, decay and splicing rates in human and yeast24,25. Neymotin et al. used in 
vivo 4tU labelling of RNA in time series followed by RNA sequencing to estimate 
synthesis and degradation rates for coding and noncoding transcripts26. With two 
minutes labelling intervals, Eser et al. used in vivo 4tU labelling and computational 
modelling to obtain global RNA metabolism and splicing rates in fission yeast 
Saccharomyces pombe27. Barrass et al. developed and applied extremely short 4tU 
labelling with high temporal resolution for measuring splicing kinetics24. With very 
short RNA labelling, as short as 60 seconds, they quantitatively measured pre-mRNA 
splicing speed for most of the budding yeast intron-containing transcripts. Transcripts 
with low stability and abundance are hardly detectable in steady state RNA and they 
are usually enriched in mutants with defective RNA degradation. Extremely short 
RNA labelling helped Barrass et al. to effectively isolate pre-mRNAs before they get 
fully spliced and to measure the metabolism of unstable RNAs such as CUTs, SUTs 
and XUTs.    
Yeast transcription elongation mutants that transcribe faster or slower than the 
wild-type (WT) can provide a useful set of strains to investigate the effect of variations 
in elongation rate on kinetic coupling of splicing. Fast and slow elongation mutants 
may reduce and increase co-transcriptional splicing, respectively, by changing the 
temporal window of opportunity for splicing. A recent splicing specific microarray 
experiment using these mutants has shown that slower elongation increases splicing 
efficiency and accelerating elongation rate reduces splicing efficiency28. The opposite 
splicing phenotypes observed in this study for elongation mutants suggest that splicing 
efficiency is kinetically coupled to transcription. A caveat of previous studies is that 
assays of splicing efficiency in elongation mutants were performed using steady state 
RNA. Because of widespread co-transcriptional splicing and very low abundance and 
stability of splicing intermediates, it is challenging to measure the co-transcriptional 
splicing kinetics after RNA has been released from transcription complex. In fact, the 
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cellular steady state RNA is the consequence of multiple dynamic processes, therefore 
studying co-transcriptional processes requires identifying and capturing the newly 
synthesized RNA from the pool of total RNA. This chapter describes metabolic 
labeling coupled with RT-qPCR, carried out to study kinetic coupling at high temporal 
resolution in yeast transcription elongation mutants. It has been shown that spliced 
RNA and excised intron stay associated with transcription elongation complex and can 
be detected by immunoprecipitation (IP) of RNAPII14. Therefore, co-transcriptional 
splicing was also directly examined in elongation mutants through measuring 
association of the spliced RNA and lariat with RNAPII. This analysis shows that 
splicing fails to keep up with fast transcription, leading to accumulation of unspliced 
pre-mRNA, whereas in the slow mutant, nascent transcripts are more rapidly removed 
through splicing than in WT cells.   
3.3 Results  
3.3.1 Characterisation of RNAPII elongation mutants 
3.3.1.1 RNAPII transcription elongation rate mutants show growth 
defects 
The trigger loop of RPB1, the largest subunit of RNAPII, is a mobile and conserved 
domain in the catalytic centre of RNAPII that is responsible for substrate selection and 
catalysis29,30. Kaplan et al made a series of point mutations in the trigger loop of Rpb1 
cloned in RPB1 CEN LEU2 plasmid and transformed the mutant plasmid, rpb1 CEN 
LEU, into a rpb1Δ strain carrying RPB1 CEN URA3 plasmid. The transformants were 
selected by their ability to grow on a plate containing 5-fluoroorotic acid. Elongation 
rates of these mutants were estimated using in vitro run-off transcription assay1. In this 
assay, the amount of full-length RNA that is transcribed during the reaction time 
provides an estimate of the RNAPII elongation rate in vitro relative to the WT. 
Throughout this thesis, RNAPII elongation mutants were used that transcribe faster 
(rpb1-G1097D) or slower (rpb1-H1085Y) than WT (RPB1). The Rpb1-H1085 residue, 
which is located in the nucleotide interacting region, interacts with NTP β-phosphate 
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and plays a critical role in nucleotide transfer in the catalytic centre31. Substitution of 
H1085 residue with Alanine (A), Phenylalanine (F), Aspartate (D), or Asparagine (N) 
is lethal1. G1097 is one of the trigger loop hydrophobic pocket residues that 
support integrity of trigger loop open state (inactive state)1. Mutating G1097 residue 
to Aspartate (D) was proposed to destabilize the open state of the trigger loop, 
providing a plausible mechanism for substrate-induced trigger loop closing (active 
state). Substitution of Rpb1-A1076, another pocket residue, with Tyrosine (T) leads to 
increase in the speed of transcription elongation similar to rpb1-G1097D32. Hereafter, 
rpb1-H1085Y and rpb1-G1097D mutants will be referred to as slow and fast RNAPII 
mutants, respectively.   
In vitro assays have estimated transcription elongation rate as ~12 nucleotide 
per second (nt/s) for WT, ~50 nt/s for fast mutant and ~1.5 nt/s for slow mutant1. It is 
reported that changing transcription elongation rate suppresses growth and severity of 
growth correlates with the degree of change in elongation rate1. Therefore, to validate 
the phenotype of fast and slow strains used in this work and compare with previous 
reports1,28, strains were grown to log phase and 10-fold serial dilutions of the cells were 
transferred to a SC-Leu growth plate. SC-Leu is a complete medium lacking leucine. 
Consistent with Kaplan et al report1, fast and slow mutants showed growth defects that 
were comparable with their perturbed elongation rates (figure 3.1a).  It remains to be 
determined whether in vivo elongation rates in these mutants are accurately 
represented by the in vitro elongation rates. However, estimation of the in vivo 
elongation rates of these mutants in human cell lines with genome-wide nuclear run-
on sequencing (GRO-seq) showed a good agreement with in vitro estimates16. To 
further validate the strains, plasmids were rescued from the strains and regions of 
interest were amplified by PCR and samples sent to Edinburgh Genomics for Sanger 
sequencing. As shown in figure 3.1b, Sanger sequencing confirmed the presence of 
the mutations in the trigger loop. In the case of rpb1-G1097D, GGT (Gly1097) codon 
mutated to GAT (Asp) and for rpb1-H1085Y, CAT (His1085) codon mutated to TAT 




Figure 3.1: Transcription mutants and their growth phenotypes. (a) In vitro elongation rate, nucleotide 
per second (nt/s), quantified by Kaplan et al using transcription run-off assay. Spotting assay performed 
in this study shows growth on SC-Lys after 3 days (right). Relative growth rate that is shown as barplot 
estimated from spotting assays and normalized to the WT (b) Chromatograms showing Sanger 
sequencing results and confirmation of the mutants.  
 
3.3.1.2 Deleting UPF1 makes fast mutant auxotroph for lysine 
amino acid 
It has been shown that mutations that increase transcription elongation rate are 
sensitive to chemical inhibitors that reduce the rate of elongation1. To test the growth 
phenotype of the strains, they were grown on a plate lacking SC-Leu and containing 
mycophenolic acid (MPA, 20 µg/ml final concentration), a drug that reduces GTP 
synthesis and consequently inhibits transcription elongation. Due to the plan for doing 
RNA sequencing (discussed in chapter 5), UPF1 was deleted from all three strains in 
order to protect mis-spliced transcripts from nonsense-mediated decay (NMD) and the 
growth phenotype of the Δupf1 strains was assayed alongside wild-type UPF1 strains. 
Spotting assays revealed that MPA inhibits growth of the fast (figure 3.2), whereas the 
slow and the WT strains were insensitive to MPA. Rpb1-E1103G, which also 
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transcribes faster than WT, was used as additional control strain. These observations 
confirm the expected phenotype of the elongation mutants1,28. Notably, the fast and 
slow mutants showed better growth when UPF1 was deleted.  
 
Figure 3.2: Growth in the presence or absence of MPA and also absence of Lys amino acid. After 
performing spotting assay as described in materials and methods, plates were incubated at 30oC and 
photographed after three days. –Lys plate was photographed after 4 days.  
All three strains contain a transposable (Ty) element in the LYS2 promoter 
(lys2-128∂, the Spt− phenotype) resulting in auxotrophy for lysine (figure 3.3a). Ty 
elements are repeated elements about 6 kilobases long and flanked by about 300bp 
direct repeats (δ sequences)33. There are around 35 Ty elements in the S. cerevisiae 
genome. Recombination of Ty elements is facilitated by δ-δ interactions33. The lys2-
128∂ phenotype is extremely stable, reverting to Lys+ (ability to grow on SC-Lys) with 
δ-δ recombination at frequency of 2 out of 10 billion cells33. SC-Lys is a complete 
medium lacking lysine. Fast elongation suppresses the effect of this element and 
enables the cells to somehow transcribe the LYS2 gene and thereby survive in the 
absence of lysine (figure 3.2)1. Conversely, when UPF1 was deleted from these strains 
(Δupf1), the fast mutant lost the ability to grow on the SC-Lys plate. To confirm this 
phenotype, an additional fast-transcribing strain (rbp1-E1103G) was tested. As can be 
seen in figure 3.2, similar to the growth phenotype of the fast strain (rpb1-G1097D), 
rbp1-E1103G does not grow on the SC-Lys plate in the absence of UPF1 gene (Δupf1). 
To check for expression of LYS2 in the Δupf1 mutants, RNA sequencing data 
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(generated for chapter 5) were examined for transcripts at the LYS2 locus using the 
UCSC genome browser. In both fast and WT strains, there is abundant transcription 
initiation at the transcription start site (TSS), but this signal is lost in the Ty insertion 
site, indicated by ‘star’ (figure 3.2). Notably, antisense RNA is also elevated more than 
two fold in the case of the fast mutant which may interfere with LYS2 expression on 
the sense strand (figure 3.3b). 
 
Figure 3.3: Ty1 insertion in promoter region of LYS2 gene. (a) Insertion of the Ty1 element into the 
5’end of the LYS2 coding region creates lys2-128∂ allele.  This insertion makes RPB1 cells Lys− as they 
only express a short non-functional transcript (black arrow), while the fast mutant allows transcription 
of LYS2 from a cryptic promoter (red arrow, bottom), somewhere within the Ty1 insertion, allowing the 
cells to become Lys+. (b) Read coverage of the Lys2 locus in the WT and fast strains with Δupf1 
mutation. Star indicates the Ty1 insertion site.  
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3.3.2 Fast and slow transcription affect co-transcriptional 
splicing of nascent RNA 
3.3.2.1 Kinetic labelling of RNA with 4tU to study co-transcriptional 
splicing  
4-Thiouracil (4tU) is a non-toxic base analogue that can be taken up by yeast and 
mammalian cells and incorporated into RNA that is being actively transcribed (figure 
3.4a). In order to get rapid 4tU incorporation in to the RNA during short periods of 
labelling, the FUI1 permease gene was over-expressed via transforming pRS426-FUI1 
plasmid into the yeast cells. In the cell, 4tU is converted to 4tUTP and incorporated 
into RNA during transcription. After treating cells with 4tU for 1, 1.5, 2.5, 5 and 10 
minutes, the yield of newly synthesized RNA was measured in all three strain. As can 
be seen in figure 3.4b, the total yield of newly synthesised RNA increases with 
labelling time.  
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Figure 3.4: 4tU labelling diagram. (a) 4tU added to the growing yeast culture gets incorporated (shown 
with S in the flask) into the newly synthesized RNA (green). RNAPII is shown in purple in the flask. 
After harvesting the cells at the indicated times, total RNA is extracted and newly synthesized RNA is 
biotinylated and affinity-selected with streptavidin beads. Newly synthesized RNA is released from 
beads with beta-mercaptoethanol (scissors). (b) Showing total yield of the newly synthesized RNA at 
the indicated times (at least three biological replicates).The amount of newly synthesized RNA increases 
with time in all strains.  
 
3.3.2.2 Altering transcription elongation rate influences the amount 
of nascent RNA that is spliced co-transcriptionally 
To gain further insight into the coupling between splicing and transcription, the 
splicing of newly synthesised transcripts produced by RNAPII elongation mutants and 
WT was examined. By briefly labelling RNA with 4tU (for 1, 1.5, 2.5, 5 and 10 min), 
nascent, thiolated RNA was biotinylated and then affinity-selected using streptavidin 
beads (figure 3.4a). Analysing the nascent RNA by reverse transcription-quantitative 
PCR (RT-qPCR) the kinetics of splicing was followed for three well-expressed intron-
containing genes, RPL39, RPL28 and ACT1. Splicing efficiency is generally 
determined by measuring levels of spliced and unspliced RNAs28. Pre-mRNA was 
measured using an amplicon for exon-intron boundary (5’SS boundary) and mRNA 
was measured by an amplicon detecting exon-exon junction (figure 3.5a).  In the fast 
mutant, a rapid increase in the pre-mRNA/mRNA ratio was observed for all three 
representative transcripts, indicating that pre-mRNA was synthesised faster than it was 
removed by splicing (figure 3.5b). This ratio declined gradually towards the steady-
state level after 2.5 min. Conversely, with the slow mutant, transcripts were spliced 
before they accumulated to a significant level such that the pre-mRNA/mRNA ratio 
was less than for the WT RNAPII even in the case of RPL28 transcripts that splice 
slowly24. These results clearly illustrate the “window of opportunity” effect; with the 
fast mutant the pre-mRNA exists for longer before it is spliced, and with the slow 
mutant the pre-mRNA is spliced very soon after synthesis. It should be noted that this 
does not mean that the rate of splicing is different in the three strains, only that it 
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happens later or sooner after transcription. Additionally, the pre-mRNA/mRNA ratio 
in total RNA was measured for 5 representative genes, finding a higher ratio than WT 
with the fast mutant and slightly lower for the slow mutant (figure 3.5c).  
Total RNA sequencing of the human cell lines has revealed a 5′–3′ gradient in 
the read coverage across the introns and exons, with higher levels of reads present in 
the 5′ end of introns, illustrating co-transcriptional splicing4. Measuring 5’SS/3’SS 
with RT-qPCR in elongation mutants showed that fast mutant reduces and slow mutant 
enhances this gradient (figure 3.5d).     
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Figure 3.5: Altering RNAPII elongation rate affects RNA splicing efficiency. (a) Diagram showing the 
location of RT-qPCR amplicons (lines below) for measuring pre-mRNA (exon–intron boundary at the 
5′SS) and mRNA (exon–exon junction) levels. Black boxes represent exons of intron-containing 
transcript or coding sequence of intronless transcript (ALG9). (b) RT-qPCR results showing pre-
mRNA/mRNA ratio for ACT1, RPL39 and RPL28 in fast (red line), slow (blue line) and WT (green 
line) strains. To correct for amount of input RNA, values for pre-mRNA and mRNA were separately 
normalized to an intronless transcript (ALG9) in the same sample. 4tU labelling was performed for 1, 
1.5, 2.5, 5, and 10 minutes (x axis), with all values plotted relative to the 1 minute value. (c) pre-
mRNA/mRNA ratio of steady state RNA for the fast and slow mutants relative to WT (green dashed 
line) measured by RT-qPCR. Error bars represent at least three biological replicates; p-value < 0.0036. 
(d) 5’SS/3’SS ratio of steady state RNA for the fast and slow mutants relative to WT (green dashed 
line) measured by RT-qPCR. Error bars represent at least three biological replicates; p-value < 0.044. 
3.4 Co-purifying nascent RNA with RNAPII  
The highly stable association of nascent transcripts with elongating RNAPII permits 
co-transcriptional splicing to be measured by analysis of transcripts that co-purify with 
RNAPII14. DNA-RNA-RNAPII ternary complex is highly stable, allowing co-
purification of the nascent transcripts directly from lysed cells by immunoprecipitation 
(IP) of RNAPII without crosslinking (figure 3.6a). Churchman and Weissman used 
RPB3 with a 3×FLAG epitope tag for IP of the RNAPII14. Strains used in this study 
had RPB3 with a TAP tag and the protocol was adapted accordingly to pull down 
transcription complex with TAP tagged Rpb3. Rpb3, the third-largest subunit of 
RNAPII, is essential and part of the central core of the polymerase complex. After 
pulling down RNAPII complex with IgG–Sepharose beads, co-precipitated RNAs 
were released, purified and analysed by RT-qPCR to quantify the pre-mRNA, mRNA 
and excised intron products of splicing (figure 3.6a). Pulldown efficiency of the 




Figure 3.6: Schematic diagram of NET-RT-qPCR protocol adapted from14. (a) Yeast culture is flash 
frozen and lysed cryogenically. Nascent RNA (green) is co-purified with RNAPII elongation complex 
using IgG–Sepharose beads. RNA finally is eluted with TEV protease and reverse transcribed into 
cDNA and analysed with qPCR. m7G refers to the 7-methylguanosine cap structure at the 5′ end of 
nascent transcripts. (b) Western blot detecting Rpb3 immunoprecipitation samples of input lysate (56 
kDa), unbound lysate and eluted protein (40 kDa) with anti Rpb3 antibody. 
 
3.4.1 RNAPII occupancy along intronless genes 
Genome-wide analysis of RNAPII density in S. cerevisiae by NET-seq has revealed 
an increase in density of RNAPII at the 5’ends of genes (figure 3.7a)14. In order to 
check the efficiency of nascent RNA pull down, it was tempting to explore the RNAPII 
density profile along the two well-expressed intronless genes, ALG9 and FMP27 and 
compare it with the total RNA. For this purpose, primers were designed across these 
genes and the amount of nascent RNA associated with RNAPII along these genes was 
measured by RT-qPCR. Indeed, the RNAPII density profile observed for ALG9 and 
FMP27 was similar to the published NET-seq RNAPII density profile (figure 3.7b). 
In all three strains, RNAPII density is higher at the 5′end near the transcription start 
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sites and reduces towards the 3’end of the genes. Notably, this profile was not detected 
when total RNA used as a control. In metazoans, RNAPII experiences a promoter-
proximal pausing event at the 5’end, which causes RNAPII to pile up before entry to 
the active elongation state. This pause is imposed by NELF and DSIF transcription 
factors and released by phosphorylation of NELF, DSIF and CTD by P-TEFb34. In 
budding yeast, the 5′ pause is less prominent due to the lack of NELF19.  
Figure 3.7: (a) Published metagene analysis of read counts for well-expressed genes (n = 471) in the 
presence and absence of α-amanitin (transcription inhibitor)14. (b) RNAPII density profile across ALG9 
and FMP27 for the fast, slow and WT strains. WT-TotalRNA is the total RNA from WT (not purified 
with IP) used as a control. Positions of the primers on ALG9 and FMP27 are shown below the plots.  
 
3.4.2 Excised lariat and mRNA association with RNAPII 
It has been shown that the excised lariat intron and the spliced RNA remain associated 
with RNAPII, probably via the spliceosome14. Therefore, measuring the association of 
mRNA and lariat with the mutant polymerases could provide insights regarding the 
co-transcriptional splicing when transcription is faster or slower than WT. Measuring 
spliced exon association with RNAPII shows that, for most of the genes tested, slower 
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transcription increases its association with RNAPII, indicating enhanced co-
transcriptional splicing, whereas faster transcription reduces co-transcriptional 
splicing compared to WT RNAPII (figure 3.8a). The exceptions are the two RP genes 
tested, RPL39 and RPL28, for which the association of the spliced RNA decreases 
similarly with both the slow and fast mutants. HRB1 has an unconventional BP 
(TACTAAT) that differs from the yeast canonical BP (TACTAAC). It appears that 
slower transcription opens the window of time for efficient recognition and splicing of 
this BP and this could explain the higher association of the HRB1 mRNA with the slow 
RNAPII. As expected14, the excised intron, in the form of a branched lariat, also stays 
associated with slow RNAPII and is increased significantly compared with WT (figure 
3.7b). Conversely, this association reduced greatly with the fast RNAPII. As a control, 
lariat was also measured in total cellular RNA. Unexpectedly, association of the pre-
mRNA is also reduced with the fast mutant and slightly increased with the slow mutant 
(figure 3.8c). Low level association of the pre-mRNAs with fast RNAPII could be due 
to co-transcriptional degradation of pre-mRNAs (figure 3.8d). Indeed, it has shown 
that  xrn1Δ/rat1-1 double mutant background stabilizes RNA in the fast mutant, 
suggesting degradation of pre-mRNAs from the 5’end, possibly due to a capping 
defect35. On the other hand, the slow mutant can potentially stabilize pre-mRNAs by 
allowing more efficient 5’capping, which leads to increased association of pre-mRNA 




Figure 3.8: Fast elongation reduces and slow elongation enhances co-transcriptional splicing. (a) 
Diagram of capturing nascent RNA transcripts (mRNA and excised intron) directly through their 
association with the DNA-RNA-RNAPII ternary complex. Red lines represent location of the RT-qPCR 
amplicons for measuring mRNA (exon–exon junction) and excised intron levels. (b) Fold enrichment 
of mRNA (b), lariat (c) and pre-mRNA (d) in each mutant relative to WT. To correct for differences in 
the amount of RNA pull down, values for pre-mRNA and lariat were separately normalized to RT-




3.5.1 Changes in growth phenotype of elongation mutants in 
the absence of Upf1 
Upf1, active in the yeast cytoplasm with RNA helicase activity, is one of the key 
proteins in the NMD pathway, implicated in rapid turnover of RNAs containing 
premature translational termination codons (PTCs). Upf1 is a non-essential protein in 
yeast and its deletion from RPB1 cells does not have an obvious effect on cell growth 
(figure 3.2), although it stabilizes RNAs containing PTCs36. Improved growth 
phenotype of RNAPII elongation mutants in the absence of Upf1 suggests that the 
NMD pathway is limiting for growth in these mutants. As the RNAPII TL promotes 
selection and catalysis of NTP substrates, it is proposed as the major contributor to 
transcription fidelity37. Thus, it seems likely that the TL elongation mutants, the fast 
and the slow RNAPII, increase in vivo nucleotide misincorporation events that could 
increase the likelihood of introducing PTCs in RNA transcripts. Indeed, it was shown 
that the rpb1-E1103G mutation and its analogous mutation in the E. coli RNA 
Polymerase that causes faster elongation, decreases transcription fidelity38,39. Upf1 
activity is ATP dependent and therefore, targeting and processing all the NMD 
substrates accumulated due to perturbed elongation mistakes would require more 
energy and time. These results would seem to suggest that inactivating the NMD 
pathway bypasses the RNA surveillance step via NMD in the elongation mutants and 
promotes the cell growth at the expense of allowing accumulation of truncated proteins 
that could be toxic.  
In spite of better cell growth on SC-Leu in the absence of Upf1, the lack of 
Upf1 suppresses the growth of the fast strain with lys2-128∂ background on SC-Lys 
plate (figure 3.2). Why the fast mutant loses this ability in the absence of Upf1 is not 
clear but three points are highlighted here. First, transcription elongation mutants alter 
TSS selection (discussed next chapter) and it was suggested that an upstream shift in 
TSS somehow enables productive initiation of LYS2 transcription from a cryptic 
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promoter within the Ty element1. This indicates that Upf1 might play a role in 
productive transcription initiation by modulating TSS selection. If this is true, there 
should be differences in the TSS selection pattern of the fast strain in the presence 
(fast-UPF1) and absence (fast-upf1) of Upf1. However, a comparison of TSS at the 
ADH1 gene between fast-UPF1 strain reported previously28 and fast-upf1 strain 
analysed by RNA-seq in this study (discussed next chapter) has revealed no difference. 
Second, as mentioned earlier, the Ty insertion in LYS2 gene  (lys2-128∂) creates a very 
stable Lys- phenotype (suppression of growth on SC-Lys) but it has shown that spt2 
and spt3 mutations increase the frequency of Lys+ revertants (growth on SC-Lys) 
significantly33. The revertants of lys2-128∂ result from δ-δ recombination, which 
excises most of the Ty element. Spt2 and Spt3 are involved in negative regulation of 
transcription. It seems possible that Lys+ phenotype of the strains in the absence of 
negative elongation factors is due to hyperactivity of transcription complex that 
somehow promotes δ-δ recombination and excision of Ty. Accordingly, growth of the 
fast mutants with lys2-128∂ background on SC-Lys likely is the result of transcription 
hyperactivity. Fast mutants lose this ability in the absence of Upf1, suggesting that 
Upf1 directly or indirectly facilitates δ-δ recombination. The first and second points 
appear to support the assumption that similar to human cells, Upf1 may have nuclear 
functions in yeast40. Third, it has been shown that the mRNA decapping complex, the 
5′ to 3′ mRNA exonuclease, Xrn1, and the NMD pathway (Upf1, Upf2, and Upf3) 
stimulate post-translational steps in retrotransposition41. Upf1 is also required for 
efficient restriction of Ty1 retrotransposition by Ty1 processing complex, and deleting 
UPF1 reduces retrotransposition41,42. These studies suggest a role for Upf1 in Ty1 
retrotransposition at post-translational steps. It also has been shown that antisense 
RNAs interfere with posttranslational Ty1 retrotransposition processing. Looking at 
the RNA sequencing data reveals at least two-fold increase in antisense transcription 
of the LYS2 gene with the fast mutant (Δupf1) relative to the WT (Δupf1) (figure 3.3). 
This indicates that the absence of Upf1 may lead to accumulation of antisense RNA 
and therefore inhibit Ty1 retrotransposition. To confirm this hypothesis, it is required 
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to measure antisense transcription of the LYS2 gene in a fast-UPF1 strain. How Upf1 
is implicated in functional LYS2 mRNA production through modulating 
posttranslational retrotransposition processes is not clear. More research on this topic 
needs to be undertaken before the association between transcription elongation 
mutants and Upf1 is more clearly understood. 
3.5.2 Altering transcription elongation rate influences the 
amount of nascent RNA that is spliced co-
transcriptionally  
There is mounting evidence for functional links between transcription and splicing, for 
example, transcription elongation can affect alternative splicing, and splicing or 
splicing defects can affect transcription3,5,7,13,19,21,43,44. The functional consequences for 
splicing of altering transcription rate have been the subject of intensive study in 
mammalian cells6,7,19,44. Several lines of evidence presented above show that RNAPII 
mutations that cause faster (Rpb1-G1097D) or slower (Rpb1-H1085Y) transcription in 
budding yeast reduce and increase co-transcriptional splicing, and they also reduce and 
increase splicing efficiency, respectively. 
In vivo 4tU labelling for a brief period revealed an increased pre-
mRNA/mRNA ratio in the fast strain, whereas slower transcription resulted in a 
modest decrease in this ratio compared to WT (figure 3.5). This indicates that splicing 
does not keep up with a faster elongating RNAPII; i.e. there is a delay after production 
of the intron (actually the 5’SS in this assay) before it is removed by splicing and, 
conversely, when transcription is slower, splicing of newly synthesised pre-mRNA 
occurs sooner after production of the intron. This does not necessarily imply that the 
rate of splicing itself is different in the three strains. These results are in accord with 
single-molecule intron tracking (SMIT) that showed greater physical distance between 
the 3’ ends of introns and the fast RNAPII compared to normal RNAPII, although they 
did not test a slow mutant2. The SMIT approach showed that, for the 87 genes tested, 
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90% of co-transcriptional splicing occurred, on average, by the time RNAPII was 129 
bp beyond the 3’SS. Results presented here suggest that splicing occurs even closer to 
slow RNAPII compared to WT. In support of this, figure 3.8b shows that, most genes 
analysed, more spliced mRNA and excised intron lariat associates with slow RNAPII 
and less with fast RNAPII compared to WT. Together, these different assays show that 
with faster elongation less splicing occurs co-transcriptionally but more of the second 
exon may be available to the splicing machinery at the time when splicing takes place, 
whereas, with slower elongation more splicing takes place co-transcriptionally and 
sooner after transcription of the 3’SS. This is consistent with the window of 
opportunity model, which proposes that slow elongation expands and fast elongation 
compresses the time available for upstream splice sites to be recognised before 
competing downstream splice sites are produced5–10. In the case of single intron genes, 
this translates to more or less time being available for splicing to occur before 3’ end 
processing occurs and transcription terminates, i.e. co-transcriptionally. For the slow 
mutant it may be that intron recognition and/or other aspects of spliceosome assembly 
are enhanced due to there being more time for co-transcriptional spliceosome 
assembly. 
Measurements of splicing efficiency by RT-qPCR of total RNA revealed an 
inverse correlation between transcription elongation rate and splicing efficiency 
(figure 3.5c). This analysis further supports that the splicing efficiency is coordinated 
with transcription rate. Slow transcription increases the splicing efficiency possibly by 
allowing sufficient time for spliceosome assembly. In contrast, the spliceosome cannot 
process all the pre-mRNAs that are produced with faster transcription, therefore 
splicing efficiency decreases. A previous study with RNAPII elongation mutants also 
documented an anti-correlation between splicing efficiency and transcription 
elongation speed in budding yeast based on microarray analysis28. Furthermore, RT-
qPCR of total RNA revealed an increase in 5’SS / 3’SS ratio with the slow mutant but 
in contrast, this ratio was lower for the fast mutant compared to WT (figure 3.5d). It 
was shown previously that 5′–3′ gradient of sequence coverage across the introns and 
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exons can be explained by co-transcriptional splicing and could be used for 
quantification of co-transcriptional splicing from RNA-seq data4,45. Enhancing and 
relaxing the 5’-3’ gradient with the slow and the fast mutants, respectively, supports 
the notion that introns are spliced more co-transcriptionally when transcription is 
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Chapter 4 Studying splicing efficiency and TSS 
selection genome-wide in elongation 
mutants 
4.1 Acknowledgement 
Statistical analyses were carried out in collaboration with Yuanhua Huang (School of 
Informatics, the University of Edinburgh). 
4.2 Introduction 
In budding yeast only about 5% of genes contain an intron, although these genes 
produce about 27% of total mRNA, as many intron-containing genes are highly 
expressed. Tuning the splicing efficiency of intron-containing transcripts plays 
important roles during meiosis and under diverse environmental stresses1–3. For 
example, the MER2 gene is constitutively transcribed in mitosis as well as meiosis and 
is efficiently spliced only in meiosis, when meiosis-specific mRNA splicing factor, 
Mer1, is expressed1. In addition, amino acid starvation inhibits the splicing of the 
majority of RP transcripts, while toxic levels of ethanol inhibits splicing of a different 
group of transcripts2. These observations have demonstrated that rapid changes in 
splicing efficiency can allow fast changes in gene expression in response to 
environmental stresses. 
Splicing efficiency is traditionally presented as the amount of pre-mRNA 
divided by the amount of mRNA for each gene. RT-qPCR is widely used to measure 
pre-mRNA and mRNA levels, with primers spanning the exon-intron boundary and 
exon-exon junction respectively. Despite the high sensitivity of the RT-qPCR 
approach, it is only feasible to measure splicing efficiency for a limited number of 
genes. To measure splicing efficiency in RNAPII elongation mutants, Braberg et al 
performed splicing-specific microarray analysis of steady state RNA4. The splicing 
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microarray chip contain three different oligonucleotide probes that allow for the 
specific quantification of differences in the levels of the pre-mRNA, mRNA and exon2 
(measuring total transcript) of intron-containing transcripts between WT and 
transcription elongation mutants. Splicing efficiency was measured by analysing the 
behaviour of pre-mRNA and mRNA against the background changes in the total level 
of transcript. This approach revealed that fast transcription reduces and the slower 
transcription increases splicing efficiency for most genes4. There are several lines of 
evidence showing that changes in RNAPII elongation rate alter alternative splicing 
decisions in mammalian cells and on a reporter gene in budding yeast5–9. Although the 
frequency of alternative splicing is low in yeast (discussed next chapter), studies have 
shown that RNAPII may slow down or pause to enhance co-transcriptional splicing10–
13. Indeed, microarray analysis demonstrated that a slow mutant favours and a fast 
mutant reduces co-transcriptional splicing efficiency likely via stretching or shortening 
the time window available for spliceosome assembly with the slow and fast mutants, 
respectively. Here, sequencing of RNA was used to carry out a comprehensive splicing 
efficiency analysis at the genome-wide scale in yeast RNAPII elongation mutants. The 
classic way of measuring splicing efficiency from RNA-seq data is based on 
comparing read counts of intronic (representing pre-mRNA), exon-exon junction 
(representing mRNA) and also exonic (representing total transcript) regions. Here, pre-
mRNA fraction (pre-mRNA reads / (pre-mRNA reads + mRNA reads) was used to 
compare splicing efficiency between strains with the DICEseq package14. This has 
allowed new insights into co-transcriptional pre-mRNA splicing and showed that fast 
transcription mostly reduces splicing efficiency of the RP transcripts and the slow 
mutant reduces splicing efficiency for most of the transcripts.  
In addition, RNA has enabled investigation into the effects of altering 
elongation rate on exon skipping and TSS and PAS selection genome wide. There are 
many studies with human cells showing that transcription elongation rates tune the rate 
of alternative exon inclusion and exclusion in transcripts with multiple exons15,16. In 
contrast, yeast only has 10 genes with three exons, including DYN2, and enhanced 
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exon skipping of DYN2 with a slow RNAPII was the first evidence of the effect of 
elongation rate on modulating exon skipping in buddying yeast6. Exon skipping was 
detected by RT-qPCR in other transcripts in yeast strains with inactivated RNA decay 
pathways but their physiological importance mostly remains unknown17,18. `This 
chapter describes an RNA-seq analysis to investigate the effect of fast and slow 
transcription on exon skipping for more genes. Furthermore, recent studies showed 
that RNAPII elongation mutants alter TSS selection pattern likely due to changes in 
efficiency of nucleotide selection and incorporation rate4,20. TSS pattern was examined 
transcriptome wide for the first time here with RNA-seq data, showing that the fast 
mutant shifts TSS upstream at most of genes and the slow mutant shifts TSS slightly 
downstream, consistent with previous primer extension analysis4,20. Also, RNA-seq 
data provide new insights regarding the effect of altering transcription rate on PAS 
selection. 
4.3 Next generation RNA sequencing 
To investigate splicing efficiency and fidelity genome-wide (fidelity is discussed in 
next chapter) in RNAPII elongation mutants, high depth RNA sequencing was 
performed on total RNA. Library preparation and next generation RNA sequencing 
was carried out at the Beijing Genomics Institute (BGI). After receiving RNA 
sequencing data from BGI, raw sequencing reads were quality controlled with 
FastQC21. All samples had good quality. STAR aligner was used to align the reads to 
the S. cerevisiae genome (sacCer3). STAR is ultra-fast and finds exon-exon junctions 
with high precision mapping strategy22. RNA sequencing was performed in two 
biological replicates. On average, 85 million unique paired-end reads were mapped 
successfully to the genome per sample (Table1). As shown in figure 4.1, the majority 
of the reads mapped to protein coding transcripts in all three strains. However, 
comparing the fast mutant with WT strain shows that expression of the protein coding 
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genes reduced almost 5%, whereas, expression of non-coding RNAs increased 
proportionally.   
 
Figure 4.1: Percentage of the reads mapped uniquely to pseudogenes, rRNAs, tRNAs, snRNAs, 
ncRNAs, snoRNAs and protein coding genes in each sample. ENSEMBL GTF file, version R64-1-1.75 




4.4 Global changes in co-transcriptional splicing 
efficiency in RNAPII elongation mutants 
As discussed in chapter 3, 4tU labelling, and IP of RNAPII showed that the fast strain 
reduces co-transcriptional splicing but the slow mutant increases co-transcriptional 
splicing. Additionally, RT-qPCR of steady state RNA revealed that the fast mutant 
increases and the slow mutant decreases pre-mRNA/mRNA ratio. Overall, these 
results indicated that the fast and slow mutants decrease and increase co-transcriptional 
splicing efficiency, respectively. To investigate how co-transcriptional splicing 
efficiency changes genome-wide in elongation mutants, splicing efficiency was 
quantified for all strains using RNA sequencing with the DICEseq package14. The 
transcripts that did not have enough intron or junction coverage, such as meiosis 
specific transcripts, were excluded from further analysis.  
It has been suggested that RP transcripts are more co-transcriptional than non-
RP transcripts23,24. Thus, splicing efficiency was measured separately for RP and non-
RP transcripts. Analysis showed that the fast mutant increases pre-mRNA/mRNA ratio 
for many RP transcripts but the slow mutant reduces this ratio for both RP and non-
RP transcripts (figure 4.2a). Reanalysis of published4 data from a splicing-specific 
microarray analysis of steady state RNA from the same fast RNAPII mutant as used 
here, and a different slow mutant, showed the same effect (figure 4.2b). Furthermore, 
analysing pre-mRNA and mRNA of several genes in the mutants revealed a negative 
correlation, so that fast mutant leads to accumulation of pre-mRNA and consequently 
reduction in mRNA levels, but more mRNA and less pre-mRNA were detected with 




Figure 4.2: (a) pre-mRNA fraction for the fast and the slow mutant in RP and non-RP transcripts, 
measured by DICEseq measured in collaboration with Yuanhua Huang from RNA sequencing data. Y 
axis shows pre-mRNA fraction in log2 scale normalized to WT. Horizontal blue line in Y axis is WT 
level. (b) Splicing efficiency of RP and non-RP transcripts measured by splicing-sensitive microarrays. 
Data were downloaded from Braberg et al (2013) supplementary file. G1097D (GD) is fast mutant and 
H1097Q (HQ) is slow mutant. Y axis shows intron over junction ratio in log2 scale normalized to WT. 
Horizontal blue line in Y axis is WT level. (c) pre-mRNA fraction (left panel, pvalue < 0.00498) and 
mRNA levels (right panel, pvalue < 0.00244) of five example genes measured by DICEseq from RNA 
sequencing data.   
4.5 Exon skipping in transcripts containing two 
introns  
At least 95 percent of mammalian transcripts undergo alternative splicing but only 10 
genes in S. cerevisiae contain two introns and evidence of alternative splicing was 
found for few of these by RT-PCR17,18. To search for evidence of exon skipping in 
RNA-seq data, reads that spanned the exon1-exon3 junction were extracted for each 
84 
 
sample and the frequency of exon skipping was measured relative to number of reads 
that aligned to exon1-exon2 junction (figure 4.3a). Analysis showed a 3-fold increase 
in skipping of the TAD3 second exon in the fast mutant (figure 4.3b). Exon skipping 
is detected with lower frequency in other two-intron transcripts but with insufficient 
read density to draw a clear conclusion (figure 4.3c). There is no sign of exon skipping 
for the highly expressed RPL7A and RPL7B, the only RP transcripts with three exons 
(figure 4.3c). 
Figure 4.3: Fast mutant enhances exon skipping. (a) Diagram showing second exon skipping of TAD3 
transcript, joining the first and third exons. Short, black lines represent junction reads. (b) Fast mutant 
increased second exon skipping of the TAD3 transcript more than two-fold. (c) Exon skipping in other 
transcripts with two introns. Skipping reads were not detected for RPL7A and RPL7B. 
4.6 Splicing polarity 
Fededa et al reported splicing with 5’ to 3’ polarity in human cells, such that inclusion 
rate of the upstream exon affects splicing efficiency of the downstream exon, but not 
vice versa19. Furthermore, inhibition of transcription elongation by 5,6-dichloro-1-
p < 2.71e-2 
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beta-D-ribobenzimidazole (DRB) treatment enhanced polarity, and when transcription 
was driven by the “more elongating” α-gb promoter, polarity was abolished19,25. A 
similar relationship was identified between the first and second introns in the yeast 
SUS1 transcript18. To investigate splicing polarity in yeast transcripts that contain two 
introns, frequency of the first (E1) and second (E2) intron retentions were obtained by 
dividing intron read counts over junction read counts (figure 4.4a). Notably, fast 
transcription shows reduction in E1/E2 ratio (p < 2.11e-2, t-test) for transcripts with 
higher E1/E2 ratio in WT (SUS1, RPL7B, YOS1, VMA9), but there was not a significant 
change (p > 0.05) in this ratio for transcripts with lower E1/E2 ratio in WT (RPL7A, 
DYN2, TAD3) (figure 4.4b). These results indicate that the fast mutant tends to abolish 
polarity and relax the E1/E2 intron retention towards 1:1 ratio for the genes that have 
higher E1/E2 ratio in WT. In the slow mutant, retention of the first intron increased 
significantly (p < 3.67e-2) in DYN2, SUS1, TAD3, and VMA9 relative to the second 
intron, but E1/E2 ratio in RPL7A, RPL7B, and YOS1, did not change significantly (p > 



















Figure 4.4: The fast mutant abolishes and the slow mutant enhances the splicing polarity. (a) Diagram 
showing the method used for measuring intron retention of the first and second introns. Short, black 
lines represent intronic or exonic reads. (b) Showing relative intron retention of the first intron to the 
second intron in 7 transcripts in WT (green) and the fast mutant (red). (c) Showing relative intron 
retention of the first intron to the second intron in 7 transcripts in WT (green) and the slow mutant 
(blue). Error bars denote two biological replicates. 
4.7 Altering elongation rate affects transcription start 
site and polyadenylation site selection   
It was shown previously by primer extension analysis that mutations that alter 
transcription elongation rate also alter transcription start site (TSS) selection in vivo 
for four tested genes4,20. For example, fast RNAPII lead to upstream shifts in TSS 
selection at ADH1, whereas a slow mutant shifted TSS downstream at this gene4,20. To 
investigate the effect of fast and slow elongation on TSS genome-wide, the distribution 
of the 5’ends of sequence reads that were partially aligned to 5’ ends of coding 
sequences (CDS) was used to estimate the TSS distance from +1 bp of each CDS. The 
average distribution of TSS estimated via this method for the WT strain agrees with 
previous studies4,26.  Consistent with primer extension analysis of RNA 5′-ends for 
ADH120, the fast and the slow mutant shifted TSS selection upstream and downstream, 
respectively, for ADH1 and genome-wide (figure 4.5). Notably, the effect of fast 
transcription, shifting TSS upstream, is stronger than TSS shifting downstream in the 
slow mutant. Moreover, TSS at RP genes are shifted further upstream by the fast 
mutant compared with non-RP genes, indicating that TSS selection at highly expressed 
RP genes is more sensitive to alteration in transcription speed. Significantly, this shift 
is further enhanced at the RP intron-containing genes (figure 4.5). Figure 4.5c shows 
that RP genes have shorter 5’UTRs, which is consistent with previous reports26. 
Analysis of TSS usage also reveals that fast transcription robustly shifts TSS upstream 
at small nucleolar RNA (snoRNA) genes, but slow elongation does not show this effect 




Figure 4.5: Elongation mutants change TSS selection. TSS changes estimated in collaboration with 
Yuanhua Huang from RNA sequencing data (a) Fast mutant shifts TSS upstream and slow mutant shifts 
it downstream at the ADH1 locus. (b) Left panel shows difference in TSS distance between fast and WT 
strains from +1 bp of coding sequence for all yeast protein coding genes (All, 6481 genes), non-RP 
intronless genes (non-RP-, 6069 genes), non-RP intron-containing genes (non-RP+, 214 genes), RP 
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intronless genes (RP-, 110 genes) and RP intron-containing genes (RP+, 88 genes). Right panel shows 
difference in TSS distance between slow and WT strains. (c) Distance of TSS from first bp of CDS of 
different groups of genes for fast, slow, and WT strains. Star inside the boxes represents mean and blue 
line is the median. p-values are obtained using t-test. 
Figure 4.6: Density plots showing read counts and coverage for 6 different snoRNAs. Y axis shows 
read counts. Vertical dashed line is an arbitrary line to compare TSS profile of the three strains. Sashimi 
plots were generated by the MISO package27. 
The formation of the 3’ ends of transcripts is an essential process, but the effect 
of altering transcription elongation rate on efficient and accurate cleavage and 
polyadenylation of protein coding transcripts is poorly understood. Here, the 
distribution of the 3’ends of sequence reads that were partially aligned to the 3’ ends 
of CDS was used to estimate the distance from the last nt of each CDS to the 
cleavage/polyadenylation sites (PAS). The PAS distribution identified in this way for 
the WT strain agrees well with previous findings28. Analysis showed that, for most of 
the genes, slower transcription shifts PAS faintly upstream (shortening the 3’UTR) 
(figure 4.7a), whereas the fast mutant does not change the PAS distribution. In the case 
of 3’end processing sites for snoRNAs, analysis demonstrates that the elongation 
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mutants do not affect 3’end processing sites in snoRNAs and, in all the snoRNAs 
analysed here, the profile of 3’end processing sites in elongation mutants coincides 
with the WT profile (figure 4.6). 
Figure 4.7: The slow mutant change PAS selection. PAS changes estimated in collaboration with 
Yuanhua Huang from RNA sequencing data. (a) Left panel shows difference in PAS distance between 
fast and WT strains from last bp of coding sequence for all yeast protein coding genes (All, 6481 genes), 
non-RP intronless genes (non-RP-, 6069 genes), non-RP intron-containing genes (non-RP+, 214 genes), 
RP intronless genes (RP-, 110 genes) and RP intron-containing genes (RP+, 88 genes). Right panel 
shows difference in PAS distance between slow and WT strains. (b) Distance of PAS from last bp of 
CDS of different group of the genes for fast, slow, and WT strains. Star inside the boxes is representing 




Recent high-throughput studies revealed that RP transcripts tend to be spliced faster, 
more efficiently and more co-transcriptionally than non-RP transcripts29,30,24. Nascent 
RNA analysis in chapter 3 showed that changes in elongation rate affect the amount 
of splicing that is co-transcriptional, with slower elongation resulting in more co-
transcriptional splicing and vice versa. In this chapter, measurements of splicing 
efficiency by RNA-seq of total RNA showed that elongation rate affects splicing 
efficiency transcriptome-wide (figure 4.2). Analysis reveals that the overall reduced 
splicing efficiency in the fast mutant is due to an effect predominantly on RP 
transcripts, whereas the slow mutant improves splicing efficiency for both RP and non-
RP transcripts (figure 4.2). Reanalysis of published microarray data4 showed the same 
effect. Together, these observations suggest that splicing of RP transcripts is more 
functionally coupled to transcription than is splicing of non-RP transcripts, and may 
indicate that it is beneficial to splice co-transcriptionally. These results argue against 
the notion that most transcripts interact equally with the spliceosome, suggesting 
instead that transcript identity is an important factor in determining splicing efficiency. 
Moreover, analysis show that this is not simply due to there being more or less 
unspliced pre-mRNA because of different decay rates in the mutants, as the level of 
spliced mRNA is elevated in the slow mutant and reduced in the fast mutant compared 
to WT (figure 4.2). Different levels of pre-mRNA and mRNA in the mutants is in 
contradiction to the proposed RNA buffering mechanism in which RNA degradation 
compensates for different synthesis rates31. In that case, the cytoplasmic exonuclease 
Xrn1 showed the strongest effect on RNA level. It would be interesting to investigate 
whether such a buffering mechanism also operates in the nucleus, where RNA splicing 
takes place. One possible explanation for higher pre-mRNA and less spliced mRNA 
in the fast mutant at steady state (figure 4.2) could be that post-transcriptional splicing 
is less efficient than co-transcriptional splicing. Interestingly, stochastic modeling 
based on high-resolution kinetic analyses of transcription and splicing during induction 
of an intron-containing reporter gene in budding yeast revealed co-transcriptional 
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splicing to be the most efficient splicing pathway, due in part to a positive feedback 
mechanism for co-transcriptional second step splicing12. However, other interesting 
possibilities are that reduced splicing efficiency in the fast mutant is a consequence of 
inefficiently capped pre-mRNAs, changes in transcription start site, changes in pre-
mRNA or mRNA stabilities, nascent RNA folding, chromatin remodelling, 
nucleosome occupancy, or failure of RNAPII to pause for splicing10,32,33.  
Using rat1 and rrp6 mutants, Egecioglu et al characterized second exon-
skipped species from the MATa1, DYN2, SUS1 and YOS1 genes17. They argued that 
these species mainly are targeted by nuclear RNA surveillance and not by NMD. 
Because exon skipping is a rare event for these genes, its physiological importance 
was thought to be subtle and remained unknown. However, in 2011, two papers 
reported that SUS1 alternative splicing responds to the cellular and environmental 
conditions and inefficient splicing of the pre-mRNA leads to defects in H2B 
deubiquitination, temperature sensitivity, mRNA export and cell growth18,34. Heat 
stress downregulates SUS1 expression by preferentially retaining the first intron that 
is subject to NMD due to introducing a premature termination codon18. Interestingly, 
truncated protein encoded from the retained intron isoform partially suppressed sus1 
phenotypes. Exon skipping was detected with low abundance, approximately 5% of 
total, and was insensitive to heat stress. Deleting MUD1 or the LEA1 or MSL1 genes 
that encode U2snRNP components enhanced the exon skipping, indicating that this 
event is regulated18. It has been shown that SUS1 cDNA only suppresses the sus1 
phenotype partially, suggesting its alternatively spliced isoform is important for proper 
cellular function18. These results indicate that intron retention and exon skipping are 
regulated for SUS1 and tight regulation of its alternative splicing is critical for the cells. 
Consistent with previous reports, RNA sequencing data analysis detected exon 
skipping for VAM9, YOS1, SUS1, TAD3, and DYN2. TAD3 showed the highest number 
of the reads supporting exon skipping in WT, which was enhanced by fast transcription 
(figure 4.3). In the case of the slow mutant, there were insufficient reads to determine 
how slow transcription affects TAD3 second exon usage. Additionally, in both 
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biological replicates there were not enough supporting reads for other genes to 
conclude how the fast and slow mutants affect their exon skipping/inclusion rate 
(figure 4.3). Not detecting exon-skipping species in steady state RNA could be due to 
their fast degradation by RNA surveillance mechanisms. Therefore, it would be better 
to assess the effects of altering transcription rate on exon skipping in nascent yeast 
RNA or using strains with inactivated RNA degradation pathway(s). Notably, no 
sequence reads were detected to indicate exon skipping for RPL7A or RPL7B, the only 
RP transcripts with two introns. It is possible that exon skipping does not occur on 
these transcripts, or only in certain physiological conditions. Alternatively, exon 
skipping might be tightly regulated in RP transcripts, which suggests a better splicing 
quality control for RP transcripts, a topic discussed in the next chapter.  
Analysis showed that fast transcription relaxes splicing polarity in yeast 
transcripts containing two introns that have relatively higher first intron retention 
(SUS1, RPL7B, YOS1, VMA9) (figure 4.4b). This is indicating that faster transcription 
allows both introns to be exposed simultaneously to the spliceosome, which results in 
the relaxing of splicing polarity, i.e. differences between intron retention of the first 
intron and second intron becomes smaller (figure 4.4b). This shows the existence of 
splicing polarity in budding yeast and supports the idea that fast transcription decreases 
or eliminates polarity and splicing polarity is determined co-transcriptionally in yeast 
similar to mammalians. Not detecting a significant change in E1/E2 ratio for the 
transcripts (DYN2 and TAD3) that this ratio is close to 1:1 ratio could be because these 
transcripts do not have splicing polarity or have a weak polarity. The fast mutant does 
not relaxes polarity for RPL7A that has higher second intron retention rate in WT. This 
is suggesting that fast transcription does not affect polarity for the transcripts that have 
higher second intron retention (less efficiently spliced). Further work is required to 
establish this and poses an interesting question for future research. If splicing polarity 
is determined co-transcriptionally, it is expected that the slow mutant would enhance 
splicing polarity and therefore reduces intron retention of the upstream intron relative 
to the downstream intron. However, slow transcription dose not significantly changes 
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E1/E2 ratio for RPL7A, RPL7B and YOS1 and unexpectedly increased intron retention 
of the first intron relative to the second intron for DYN2, SUS1, VMA9 and TAD3 
(figure 4.4c). It could be possible that changes in splicing polarity in the elongation 
mutants is a consequence of inefficiently capped pre-mRNAs, changes in transcription 
start site, changes in pre-mRNA or mRNA stabilities, nascent RNA folding, chromatin 
remodelling, nucleosome occupancy, or failure of RNAPII to pause faithfully for 
splicing. More research on this topic needs to be undertaken before the association 
between RNAPII elongation rate and splicing polarity is more clearly understood. 
Recent primer extension analyses revealed that fast transcription shifts TSS 
upstream at ADH1, HIS3, PMA1 and GAL1 and slow transcription shifts TSS 
downstream at ADH1 and GAL1, creating longer and shorter 5’UTRs, respectively4,20. 
There is accumulating evidence that 5’UTRs play important roles in post-
transcriptional gene regulation and yet the role of 5’UTRs in regulating co-
transcriptional processes is largely unknown26,35,36. According to the scanning model, 
start site selection occurs in a polar fashion, with abortive upstream initiation leading 
to increased productive downstream start site selection, and vice versa20,37. As 
described by Kaplan et al, fast RNAPII mutants with increased nucleotide 
incorporation activity make normally abortive upstream initiations become productive, 
whereas abortive downstream initiations become productive with a slow RNAPII that 
has reduced catalytic activity20. For the first time, RNA sequencing here provides new 
insights regarding the effect of altering transcription rate on selection of TSS genome-
wide (figure 4.5). TSS shift mainly upstream with fast mutant and the strongest effect 
on TSS selection is observed with RP transcripts, shifting TSS further upstream. Slow 
transcription slightly shifts TSS downstream and there is not any difference between 
RP and non-RP transcripts (figure 4.5). The fact that the fast mutant has stronger effect 
on TSS than the slow mutant is compatible with previous reports4,20.  From four tested 
genes by Kaplan et al20, the fast mutant shifted TSS upstream in all four genes but the 
slow mutant shifted TSS downstream only with two genes20. Why TSS shifted further 
upstream in RP transcripts with the fast mutant is not clear and it might be correlate 
94 
 
with their higher expression. However, no correlation is detected between expression 
level of the transcripts and TSS selection in this study. It is also unclear why the fast 
mutant exerts a stronger effect on TSS selection of RP intron-containing genes. 
However, this also begs the question of whether changes in TSS exert a significant 
impact on splicing efficiency. It has been reported that mutations in general 
transcription factors TFIIB (sua7-3) and TFIIF (tfg2Δ261-273) that cause downstream 
and upstream TSS selection, respectively, do not alter splicing efficiency 
significantly4. Transcriptome-wide analysis here, for the fast mutant shows stronger 
TSS shifts for RP intron-containing transcripts that also show the strongest effect on 
splicing efficiency (figure 4.2 and Figure 4.5). It could be simply a coincidence that 
the fast transcription enhances upstream TSS selection in RP intron-containing 
transcripts and also reduces their splicing efficiency. However, further work is 
required to establish whether TSS selection and splicing efficiency are interdependent. 
Interestingly, the fast mutant shifts TSS selection upstream strongly with snoRNAs 
demonstrating that the effect of altering RNAPII elongation rate on TSS selection in 
mRNAs and snoRNAs is similar (figure 4.6 and Figure 4.5). Whether this would affect 
snoRNAs processing or their functions is an interesting question for future research. 
In the case of PAS selection, small changes were observed with the slow mutant 
moving cleavage/polyadenylation a few bases upstream compared to WT (figure 4.7). 
As 3’ end formation is coupled with transcription, it seems likely that slow 
transcription enhances selection of upstream PAS by allowing more time for their 
recognition38. Use of alternative PAS could potentially affect stability, localization and 
translation efficiency of transcripts39. In contrast, for all snoRNAs analysed, the 
processed 3’ ends are the same in the elongation mutants as in WT. Overall, these cases 
support the view that TSS selection in protein coding and snoRNAs is more sensitive 
to alterations in transcription elongation rate than selecting of PAS or processed 3’ 
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Chapter 5 Splicing fidelity is sensitive to 
transcription elongation rate 
5.1 Introduction 
More than 95% of human protein-coding transcripts are alternatively spliced and 
splicing patterns can be regulated distinctively during different developmental, tissue-
specific, or pathology-specific stages1,2. Splicing quality control mechanisms are 
thought to monitor the configuration of splicing complexes and whether optimal versus 
suboptimal splice sites are appropriately distinguished within the splicing machinery3. 
Low specificity in recognition of splice sites would cause insertions, deletions, and 
frame shifts in mRNA. Recent findings have opened new insights, showing that 
alternative splicing could also be important for the expression of some budding yeast 
genes. For example, intron retention in PTC7 transcripts and alternative splicing of the 
3’ end intron of FES1 create mRNAs that code for different protein isoforms4,5. Also, 
alternative 5’SS use in SRC1 transcripts results in different cellular localization of the 
resulting Src1 protein isoforms, and alternative 3’SS splicing upon heat shock 
regulates expression of the APE2 gene6,7. Although, alternative splicing events in yeast 
that give rise to functional transcripts are rare, there are hundreds of non-productive 
events that introduce stop codons in mRNAs, which may couple with NMD to tune 
overall gene expression by down-regulating the nonsense spliced isoform8–10.  
In budding yeast, selecting the optimal splice sites to generate the correct 
spliced isoforms is determined by splicing factors (e.g. U1 and U2 snRNPs and 
associated proteins) and the selection is monitored by fidelity mechanisms. DExD/H-
box ATPases are implicated in promoting fidelity at distinct steps in the splicing 
process to reject and discard suboptimal substrates3,11. Genetic mutations that disrupt 
ATPase activity of these factors was shown to increase the productive splicing of 
suboptimal substrates11. As most splicing occurs co-transcriptionally, quality control 
mechanisms that promote splicing fidelity should also occur co-transcriptionally. 
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While there is a robust body of evidence demonstrating that transcription elongation 
rate affects alternative splicing decisions in higher eukaryotes, only one study in yeast 
showed the effect of transcription rate on alternative splicing of a cassette exon using 
a DYN2 reporter gene2,12,13. DYN2 has two introns and mutating the branch point (BP) 
of the first intron enhances second exon skipping indicative of rejecting the suboptimal 
BP splicing by fidelity mechanisims12. Exon skipping was partially prevented with 
slower transcription showing that slower transcription reduces BP fidelity allowing to 
utilize suboptimal BP12. These observations support the hypothesis that the kinetic 
coordination of transcription elongation and splicing is important for splicing fidelity, 
in this case for correct recognition of the BP in yeast and rejecting suboptimal splicing 
substrates. Transcription-dependent BP fidelity raises the question of whether fidelity 
of selecting optimal vs suboptimal splice sites in yeast is adjusted by transcription 
elongation rate. A splicing-dependent transcriptional pause at the 3′ ends of introns has 
been proposed to correspond to a splicing fidelity checkpoint14. Furthermore, a branch 
point mutation caused RNAPII accumulation on the intron of a reporter gene 
suggesting the existence of a transcriptional elongation checkpoint that may promote 
splicing fidelity15. It is not known whether these quality control steps occur faithfully 
when transcription is faster or slower than normal.  
How elongation rate affects splicing fidelity in budding yeast raises the 
question of whether faster and slower transcription have the opposite effect on splicing 
fidelity as might be predicted by the kinetic coupling model. Using deep RNA 
sequencing, for the first time, splicing fidelity was determined in yeast transcription 
elongation mutants in which UPF1 was deleted in order to protect mis-spliced 
transcripts from nonsense-mediated decay (NMD). Results show that both fast and 
slow transcription reduce splicing fidelity mainly in ribosomal protein (RP) coding 
transcripts. Analysis reveals that splicing fidelity largely correlates with intron length, 
secondary structure and splice site score.  
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5.2 Filtering RNA sequencing data   
After aligning the reads to the genome, all detected exon-exon splice junctions were 
divided into two groups, known and novel. The known junctions are those that are 
annotated in GTF file (ENSEMBL, version R64-1-1.75) and the novel junctions result 
from splicing events that are not annotated in the GTF file. To reduce noise and remove 
genes with low coverage some genes were excluded from further analysis. 
Mitochondrial genes containing group I or group II introns were excluded because they 
are not spliced by spliceosomes. Meiosis specific genes that are not expressed during 
vegetative growth were also filtered out from further analysis. In addition, genes 
containing more than one intron (10 genes in total) were excluded to simplify initial 
data analysis. Next, from the remaining intron-containing genes, those that did not 
have novel events or had less than 5 unique supporting reads for novel junctions were 
also filtered out. Table 5.1 lists the excluded genes and the reason for their exclusion. 
Table 5.1 excluded genes  
HAC1  Not spliced by spliceosome  




















AMA1 Meiosis-specific, only significantly 























































5.3 Altering RNAPII elongation rate affects splicing 
fidelity  
After filtering, 244 novel splicing events were retained that had at least 5 unique reads 
in both replicates of one of the strains, and the splicing error frequency (SEF) was 
calculated for each novel event (figure 5.2a, see also Materials and Methods). Figure 
5.1a shows 4 types of alternative splicing events studied in this chapter; alternative 
upstream 5’ splice site (u5’SS), alternative downstream 5’ splice site (d5’SS), 
alternative upstream 3’ splice site (u3’SS), and alternative downstream 3’ splice site 
(d3’SS). Figure 5.1b shows the number of novel junction reads detected in fast and 
slow mutants compared with wild type. It indicates that increasing transcription speed 
promotes use of novel junctions by the splicing machinery.  
Figure 5.1 Alternative splicing events and their read counts in the mutants. (a) Different types of the 
alternative splicing events. (b) Total number of novel reads in each strain. To compare total amount of 
novel reads in each strain, reads normalized to sequencing depth. 
ns 
p <  1.12e-8 
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Further analysing the novel events showed a marked difference in the average 
SEF of RP transcripts compared to that of non-RP transcripts in the WT strain (figure 
5.2b). The SEF of RP transcripts ranges from 1 in 100 000 up to 1 in 250, while in the 
case of non-RP it ranges from 1 in 100 up to 7 in 100. Therefore, the observed average 
splicing error rate for RP transcripts is orders of magnitude lower than that of non-RP 
transcripts despite the higher expression level of RP genes. To investigate if novel 
splicing events are the consequence of random splicing errors, correlation between 
mRNA abundance and SEF was examined in all three strains. This shows that the SEF 
and the mRNA abundance are anti-correlated (figure 5.2c), indicating that the 
detection of alternative splicing events in high depth RNA-seq data is not an indirect 
result of the higher number of reads for transcripts with higher expression. 
Figure 5.2: Changes in splicing error frequency in fast and slow strains. (a) Diagram showing how SEF 
of novel splicing events was measured using an alternative upstream 3’SS event as an example. (b) 
Distribution of the splicing error frequency in RP (blue box) and non-RP (red box) intron-containing 
transcripts in WT strain. The p-value was obtained by t-test. (c) Negative correlation between mRNA 
(both RP and non-RP) abundance and average splicing error frequency in fast (red), slow (blue) and 
WT (green). mRNA abundance was estimated from the number of reads aligned to the exon-exon 
junctions. Pearson correlation coefficient and p-value for each strain were: fast (R2=-0.82, p=1.02e-33), 
slow (R2=-0.81, p=1.80e-31) and WT (R2=-0.85, p=5.53e-38). (d) Violin plot showing distribution of 
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SEF of non-RP and RP intron-containing transcripts in fast and slow mutants normalized to WT. This 
plot includes all novel splicing events whose SEF was significantly different in mutants relative to WT 
(Fisher’s exact test (p < 0.01). Points above dashed line (zero) are novel events with higher SEF than 
WT (reduced fidelity), points below dashed line are novel events with lower SEF than WT (improved 
splicing fidelity).  
Using Fisher’s exact test (p < 0.01) to determine which novel splicing events 
occur more or less frequently in the fast mutant relative to WT, 59 were identified in 
RP transcripts, of which 47 have significantly increased SEF but only 12 have a lower 
SEF (figure 5.2d). This reveals an ~4:1 ratio of reduction in splicing fidelity (higher 
SEF) over increase (lower SEF) in the fast mutant (p < 5.16e-05, Wilcoxon test). In 
comparison, 29 novel events in non-RP transcripts show significant changes in their 
SEF relative to WT, with a 1:1 ratio of reduction (15 events) versus increase (14 
events) in fidelity observed for this group (p > 0.05). With the slow mutant 49 novel 
events were identified in RP transcripts, with 30 of these having higher SEF and 19 
lower SEF, which reveals an ~1.5 ratio of reduction in splicing fidelity over increase 
(p < 4.89e-02) (figure 5.2d). In addition, 27 novel events were detected in non-RP with 
higher (12 events) or lower (15 events) SEF, which was similar to the 1:1 ratio in 
fidelity changes observed with the fast mutant (p > 0.05) (figure 5.2d). Notably, fast 
and slow transcription did not necessarily reduce or increase utilization of a specific 
event in opposite direction. For instance, utilization of an alternative downstream 5’SS 
in RPL37A increased only with fast transcription. However, both fast and slow mutants 
increased use of an alternative upstream 3’SS in RPL26B (figure 5.3a). Collectively, 
these results demonstrate that fidelity of splicing RP intron-containing transcripts is 
more sensitive to changes in transcription elongation rate than for non-RP transcripts. 
There are some novel events that occur with much higher frequency, for example in 
IWR1 and SPT14, in which the alternative (annotated and novel) events occur with 
almost equal frequency, suggesting that they could potentially produce two major 




Figure 5.3: (a) Use of novel splice sites in RPL37A and RPL26B. Sashimi plots were generated with 
MISO package16. Arcs represent junction reads connecting first and second exon borders. Resulting 
isoforms drawn at the bottom of the plot. Y axis shows Reads Per Kilobase of transcript per Million 
mapped reads (RPKM) in each sample. (b) High splicing error frequency of two alternative splicing 
events in IWR1 and SPT14. IWR1:d3:19 is a novel 3’SS 19 nucleotides downstream of the annotated 
3’SS. SPT14:u3:25 is a novel 3’SS 25 nucleotides upstream of the annotated 3’SS. Error bars represent 





5.4 Distance of alternative novel splice sites from 
annotated splice site 
The position distribution of the novel alternative splicing events in the WT strain 
shows that they occur less than ~400 nucleotides from the annotated splice sites (figure 
5.4a). Strikingly, most of the alternative 3’ splice sites (3’SSs) were found in a very 
short distance from the annotated 3’SS and there were only half as many alternative 
5’SSs. Although there are twice more alternative 3’SS events, as can be seen in boxplot 
in figure 5.4a, alternative 3’SSs and 5’SSs have similar SEF distributions in RPs and 
non-RPs. Figure 5.4b shows the positions of novel splicing events whose SEF is 
significantly different in the fast or slow mutant compared to the WT. As can be seen 
in this figure, the number of distinct novel 5’SSs and 3’SSs with higher SEF than the 
WT (lower fidelity) is greater in the fast than the slow mutant. This suggests there is 
more reduction in splicing fidelity with the fast mutant as mentioned earlier (see figure 
5.2). Because the first exon is generally short in yeast, the majority of the u5’SS events 
occur less than ~50 nucleotides distance from the annotated 5’SS (a5’SS). However, 
RPL39 and VPS29 have u5’SS occurring 358 and 319 nucleotides upstream of a5’SS, 
respectively, with the fast mutant (figures 5.4a,c). This indicates that transcription 
started upstream in these genes with the fast mutant, resulting in utilization of these 
cryptic u5’SSs. Unlike most of the novel 3’SS events that are very close to annotated 
3’SS likely due to optimal distance constraint from branch point (BP) (BP-3’SS)7, 
d5’SS events spread in a window of 400 nucleotides from a5’SS (figure 5.4a,b). This 
is probably due to proximity of the BP to the a3’SS that gives more space (5’SS-BP) 
for d5’SS events to occur. The majority of the novel alternative splicing events 
introduced premature translation termination codons in the coding region of the spliced 
RNA, which would normally be recognized by the NMD system leading to early 
transcript degradation.  
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Figure 5.4: (a) Distribution of novel splice sites that have at least 5 unique reads in the WT strain, 
plotted relative to the annotated 5’SS (left plot) or 3’SS (right plot). d3 is downstream and u3 is upstream 
novel 3’SSs, and d5 is downstream and u5 is upstream novel 5’SSs. Last number at each point is the 
distance in bases from annotated splice site. Boxplot is showing SEF distribution of the alternative 5’SSs 
and 3’SS in RPs and non-RRs. Two events with the highest SEF are highlighted for each group. (b) 
Distribution of novel splice sites whose SEF is significantly different in the fast and slow mutants 
relative to WT. * is p_value < 0.05, ** is p_value < 0.001. (c) Use of U5’SS in RPL39 (-385 bp from 
annotated 5’SS) and VPS19 (-319 bp from annotated 5’SS) increased with fast transcription. Sashimi 
plots were generated as describe for figure 5.3. 
Meyer et al7 have suggested that spliceosomes can use any 3’SS located within 
an optimal distance (10 to 50 nucleotides (nt)) downstream of the BP, and that 
achieving and selecting the optimal 3’SS is strongly influenced by RNA structures that 
make optimal 3’SS more accessible while masking suboptimal 3’SSs. Here, the results 
show that novel upstream 3’SSs are mainly restricted to within the annotated BP-3’SS 
region and they occur in a window of ~50nt from the annotated 3’SS (figure 5.4a). 
Novel upstream 3’SS events that occur further upstream of the annotated BP probably 
make use of suboptimal BPs further upstream. For example, there are two upstream 
novel 3’SS events in RPL13B located 330nt and 322nt from annotated 3’SS. These 
events probably make use of a cryptic BP (AACTAAT) which is detected by lariat 
sequencing7 and located within the optimal distance from these novel 3’SS, 21 and 13 
nucleotides, respectively (figure 5.5a). Interestingly, the SEF of these novel events in 




transcription, most likely due to increased utilization of cryptic BPs further upstream 
of the annotated BP (figure 5.4b). Howe et al showed that mutations that create a 
suboptimal BP sequence in the first intron of DYN2 caused second exon skipping and 
that the defect was partially alleviated by slower transcription12. This suggests that 
slow transcription provides more time for the assembling spliceosome to select the 
suboptimal BP (within the first intron) before transcription of the competing 
downstream BP (within the second intron), indicative of reduced BP fidelity. However, 
results presented here suggest that both fast and slow mutants reduce BP fidelity and 
thereby increase utilization of suboptimal BPs further upstream of the annotated BP 
leading to splicing of proximal cryptic 3’SSs. Meyer et al have also reported that there 
is a cryptic 3’SS between BP and annotated 3’SS of RPS23B and secondary structures 
mask this 3’SS and make annotated 3’SS more accessible to the spliceosome7. 
Interestingly, the fast mutant enhances use of this suboptimal 3’SS, suggesting that 
faster transcription disrupts the structure of pre-mRNA in this region, making 
suboptimal 3’SS more accessible for splicing (figure 5.5b). However, the elongation 
mutants did not increase SEF of an alternative 3’SS event in APE2 (APE2:u3:18), 
which was shown to be spliced with higher frequency upon heat shock, probably 
because of unstable RNA structure in BP-3’SS region in higher temperature7,17. 
Instead, both faster and slower transcriptions increased SEF of a further upstream 
alternative 3’SS event in APE2 (APE2:u3:25) (figure 5.5e) 
Downstream novel 3’SSs occur very close to the annotated 3’SS (figure 5.4a), 
presumably constrained by the optimal distance between BP and 3’SS; if they occur 
further downstream their distance from BP will get longer than optimal and could 
negatively affect spicing. The frequency of ‘AG’ dinucleotides (potential 3’SSs) on 
the second exon confirms that the lower frequency of selecting further downstream 
novel 3’SS events is not due to lower frequency of ‘AG’ dinucleotides (figure 5.5c). 
Further downstream novel 3’SSs can use cryptic BPs. For example, lariat sequencing 
detected two additional BPs in TDA5 downstream of the annotated BP. These 
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suboptimal BPs can modulate splicing of suboptimal downstream 3’SS events 
occurring 127 and 137 nucleotides from annotated 3’SS (figure 5.5d).  
 
Figure 5.5: (a) Position of the cryptic BP and novel splice sites at 5’end of the intron in RPL13B. 
Annotated BP is highlighted with green, cryptic BPs identified with lariat sequencing18 highlighted with 
grey, intron sequence is shown in lowercase letters, novel 3’SS are highlighted with yellow, partial 
sequence from exon2 is shown in uppercase letters. (b) RPS23B:u3:17 shows enhanced use of novel 
3’SS shifted 17 nucleotides upstream of annotated 3’SS. Error bars are for two biological replicates. (c) 
Density of ‘AG’ dinucleotides in the region between annotated BP position and 50 nucleotides into 
exon2 of all intron-containing transcripts. The highest density belongs to the ‘AG’ of the annotated 
3’SS.  (d) Position of the cryptic BPs and novel 3’SSs at TDA5. (e) APE2:u3:18 shows use of novel 
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3’SS shifted 18nts upstream of annotated 3’SS (left) and APE2:u3:25 shows use of novel 3’SS shifted 
25nts upstream of annotated 3’SS (right). Error bars are for two biological replicates. 
5.5 Detecting introns in genes known to be intronless 
Approximately 95% of S. cerevisiae genes are intronless. Thanks to the depth of RNA 
sequencing, cryptic introns supported by at least five unique reads were identified in 
140 normally intronless transcripts. Analysis reveals that the fast RNAPII increases 
splicing of these cryptic introns (p < 4.45e-02, Wilcoxon test) but the slow mutant does 
not affect use of cryptic introns significantly (p > 0.05). Splicing of cryptic introns 
mainly introduces premature translation termination codons (PTCs), leading to 
degradation by NMD. Notably, some cryptic introns found in the WT strain were 
insensitive to alternation in transcription speed (figure 5.6b). A good example is PRP5, 
which is required for prespliceosome formation and annotated as an intronless gene in 
ENSEMBL and Saccharomyces genome database (SGD) but RNA-seq data revealed 
a 167 nt intron with canonical splice sites (5’SS/GTATG , AGCAG/3’SS) and branch 
point (TACTAAC) sequence (figure 5.6c). The 5’SS of the intron begins two 
nucleotides upstream of the coding sequence, which means splicing of the intron 
would disrupt the conventional start codon (ATG) according to the current ENSEMBL 
annotation. Schreiber et al19 reported the existence of this novel intron based on much 
fewer reads. The spliced form is not the only expressed isoform, as figure 5.6c shows, 
there are many reads that detect unspliced PRP5 transcripts. The spliced isoform could 
have alternative functions or could act as a tool to down-regulate gene expression in 
specific physiological conditions via coupling with NMD. Interestingly, in addition to 
the main intron (intron 1 with highest coverage), there are two u3’SS (3 and 8 
nucleotides upstream) and two d3’SS (12 and 23 nucleotides upstream) in PRP5. 
u3’SS with eight nucleotides shift is the second major isoform that could potentially 
disrupt the open reading frame of the main spliced isoform.  
 Interestingly, splicing of the intron reported at the 3’ end of FES14 is affected 
differentially with elongation rate. Two-fold induction of the FES1 shorter isoform 
(using a promoter-proximal polyadenylation site) with the fast mutant and a slight 
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increase in splicing of the intron (generating a longer isoform) with the slow mutant 
suggest that FES1 splicing is regulated co-transcriptionally (Fig. 5.6d). This is 
consistent with preferential induction of the shorter isoform due to increased 
transcription upon heat shock with Hsf14. Interestingly, slight increase in splicing of 
the intron (selecting 5’SS and recruitment of the spliceosome instead of selecting the 
downstream polyadenylation site) with the slow mutant is consistent with kinetic 
competition observed in selecting upstream polyadenylation sites with slower 











Figure 5.6: Cryptic splicing of normally intronless transcripts. (a) Violin plots show the occurrence of 
cryptic splicing events within normally intronless transcripts in the fast and slow mutants normalized to 
WT. This plot includes all novel splicing events with significantly different SEF in mutants relative to 
WT (Fisher’s exact test (p < 0.01). Points above the dashed line (zero) are splicing events with SEF 
greater than WT (reduced fidelity). Points below the dashed line are the events with improved splicing 
fidelity compared to WT. (b) Intronless genes containing a cryptic intron whose SEF was insensitive to 
altered transcription elongation rate. SEF is the average of all biological replicates. Black bars indicate 
standard deviation. (c) Read density plot showing position of the intron in PRP5. (d) Splicing of FES1 
intron. Numbers show coordinates on minus strand of chromosome II. Intron (solid line) is 127 
nucleotides, and dashed lines with down triangle sign shows where splicing occurs at 3’end of the 
transcript. Splicing of the intron generates a longer isoform.  
5.6 Second intron detection within intron-containing 
genes 
Cryptic introns were also found within the second exons of some intron-containing 
transcripts (Table 5.2). For example, a cryptic intron in the second exon of RPL30 was 
spliced with a frequency of 0.7 percent relative to the annotated intron. The cryptic 
intron has GTAAG as 5’SS which spliced mainly to GAAAG/ 3’splice site or 4 base 
pairs shorter to TTGAG/ 3’SS (Table 5.2). Upstream of the 3’SS of the novel intron, 
the best match to the branch point consensus is the suboptimal CGCTAAC. Existence 
of this intron was reported with much fewer reads19. It has been shown that Rpl30 
binds to RPL30 pre-mRNA and prevents U2-snRNP association with the branch point 
while allowing 5’ splice site recognition by U1-snRNP20. Blocking splicing of the 
annotated intron in RPL30 could favour splicing of the downstream novel intron that 
would disrupt the open reading frame. Gould et al reported finding an unusual AT-AC 
intron nested inside the annotated intron of RPL3018, but neither this study nor two 
other studies9,19 found evidence for such an intron. AT-AC intron splicing takes place 
in metazoans by a distinct splicing machinery which yeast does not have21. In addition, 
the sequences of the 5’ and 3’ splice sites of the AT-AC intron reported in RPL3018 
deviate considerably from consensus AT-AC intron splice sites22. The second example 
of a cryptic novel intron within a second exon is a 62 nucleotides long novel intron in 
the second exon of RPS23B with a frequency of 0.07 percent. This event and also the 
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novel splicing event in the second exon of RPL30 would disrupt the open reading 
frame. Previously, only RPL30 was reported to have a novel intron in the second exon. 
Here other genes like this are reported (Table 5.2). The existence of these novel introns 
could provide a tool for the cells to repress expression of a particular gene by directing 
spliceosome machinery towards non-productive splicing and therefore promoting the 
nuclear turnover of spliced RNA36. 
Table 5.2: List of additional introns detected within second exons of the intron-containing genes. Fast, 
slow and WT columns show read counts (normalized to depth of sequencing) mapped to each novel 
junction in each strain. Length column is the length of the novel intron.  
5.7 Features associated with splicing fidelity 
In order to identify features that might be responsible for modulating splicing fidelity, 
the correlation between splicing error rate in all three strains and various transcript 
features, including intron length, predicted intron secondary structure (i.e., free folding 
energy, normalized by the intron length), 5'SS and 3'SS scores, and frequency of 1- to 
3-mers in the intron were investigated. Figure 5.7a shows features that were identified 
to have significant correlation (p < 0.05) with splicing error rate. In the case of intron 
secondary structure, transcripts with less stable structure (higher free folding energy) 
118 
 
have higher SEF (p < 6.13e-10) (figure 5.7b). There is also a significant negative 
correlation between the intron length and SEF indicating that shorter introns are more 
susceptible to splicing errors (p < 1.19e-23) (figure 5.7c). This leads to the prediction 
that within pairs of RP paralogs that have introns of different lengths (but very similar 
or identical exons), the one with a shorter intron will have higher SEF than the other. 
Indeed, this is the case for RPL16A/B, RPL27A/B and RPL43A/B (figure 5.7d). As 
might be predicted, 3’SS score anti-correlates with splicing error rate (p < 2. 94e-13) 
(figure 5.7e). Notably, the effect on splicing error rate of having a poor 3’SS score is 
also significantly greater within RP genes (p < 1.94 e-2). Taken together, greater SEF 
(lower fidelity) correlates with shorter introns, less stable intron secondary structure 
and poor 3’SS score. Additionally, analysis shows that novel introns in RP transcripts 
whose use increases with fast or slow mutants have significantly higher predicted free 
energy (figure 5.7f). In contrast, events that are less frequent with the RNAPII mutants 
do not have different free energy compared to annotated introns. This suggests that 
selection of novel introns with less stable secondary structure increases with changing 
transcription elongation rate. It is well stablished that budding yeast introns have 
highly conserved splice sites. Sequence logos were generated for 5’ and 3’ splice sites 
of novel introns, finding that the novel introns predominantly use suboptimal splice 
sites (figure 5.7g). The polypyrimidine tract preceding the novel 3’SS also shows a 
relaxation from the consensus sequence, highlighting the significance of the 
polypyrimidine tract sequence in correct recognition of the 3’SS.  
Using features discussed here and other features listed in figure 5.7a to predict 
the splicing error rate by a random forest regression model reveals a good correlation 
(R = 0.804) between observed and predicted splicing error rate, suggesting that these 
features play important roles in splicing fidelity (figure 5.7h). An interesting question 
was, can these features distinguish novel and known introns from a pool that have both 
kind of introns? To answer this question, novel and known intron sequences were 
pooled together and a random forest classifier used to differentiate novel and known 
introns. Figure 5.7h shows a good sensitivity and specificity for classifier for 
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differentiating novel and known introns from a mixed pool (AUC=0.782, much better 





Figure 5.7: Features associated with splicing error rate. Analysis of features associated with splicing 
fidelity and measuring correlation between observed and predicted features were carried out in 
collaboration with Yuanhua Huang (a) Pearson’s correlations between splicing fidelity and sequence 
patterns shows the significantly correlated features (p < 0.05) to SEF. Green represents positive 
correlation and blue represents negative correlation. "T" and "F" prefixes are used to show whether 
features come from annotated or novel introns, respectively. (b) Red points represent novel events in 
non-RP transcripts and blue points denote RP transcripts. Positive correlation between delta G of intron 
(see methods) and average SEF of the transcripts. Delta G of intron was divided by the intron length to 
achieve delta G per nucleotide. More negative delta G values represent more structured introns. (c) 
Negative correlation between intron length and average SEF. (d) Average SEF of three pairs of paralogs. 
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Paralogs with shorter intron length (IL) have higher splicing error frequency. (e) Negative correlation 
between 3’SS score (see methods) and average SEF. The score expresses how similar the splice sites 
are to the budding yeast 3’SS consensus. (f) Correlation between splicing fidelity in fast and slow 
mutants and intron delta G per nucleotide of known and novel RP introns. The p-values were obtained 
by t-test. (g) Sequence logos were generated for 5’ and 3’ splices sites of all novel alternative splicing 
events. For annotated introns, sequence logos were generated only from splice sites of transcripts that 
had novel alternative splicing events. (h) Correlation between observed and predicted SEF. 
5.8 A comprehensive database of alternative and 
cryptic splicing events for budding yeast  
Merging the list of unannotated (according to ENSEMBL) splicing events found here 
with those reported in most recent studies creates a database of alternative and cryptic 
splicing events for budding yeast. Including 21 alternative splicing events that have 
been reported repeatedly9,18,19 and hundreds of new splicing events that are not 
reported in those dataset (figure 5.9).  To build a more comprehensive database, 
alternative splicing events that are detected in other studies with RT-PCR, RNA-
sequencing or predicted with computational methods also need to be included17,23–25. 
Figure 5.8: Venn diagram showing overlap between all novel splicing events with at least 5 unique 
reads found in this work and three published lists of alternative splicing events in budding yeast (see 
main text for references). The novel splicing events detected in this work that were also reported in all 




Results here show that RNAPII elongation mutants affect alternative splicing and 
splicing fidelity transcriptome-wide in budding yeast. Significantly, results show that 
the relationship between transcription elongation and splicing fidelity is not readily 
explained by the commonly accepted definition of the window of opportunity; both 
fast and slow transcription reduce fidelity of RP transcripts. In chapter 4, it is shown 
that elongation rate affects splicing efficiency, with the efficiency of splicing RP 
transcripts being significantly more sensitive to changes in elongation rate than non-
RP transcripts. Accordingly, results presented in this chapter show that although RP 
transcripts are highly abundant and, in general, are spliced with high fidelity (figure 
5.2), their splicing fidelity is reduced by changes in transcription speed, whether faster 
or slower. Together, these observations suggest that splicing of RP transcripts is more 
functionally coupled to transcription than is splicing of non-RP transcripts, and may 
indicate that it is beneficial to splice co-transcriptionally. Results also indicate that 
high fidelity correlates with high splice site score, longer and more highly structured 
introns; all features that are typical of RP introns (figure 5.7). It seems likely that RP 
introns have evolved for maximum splicing fidelity to ensure optimal expression of 
these abundant and vital components of the translation machinery. In contrast, non-RP 
transcripts are, on average, spliced with lower fidelity than RP transcripts but are less 
sensitive to changes in transcription elongation rate, when fidelity can be increased or 
reduced with the same likelihood. The observation that splicing fidelity of non-RP 
introns is less sensitive to changes in splicing speed may indicate that their splicing is 
already at the lower acceptable limit of fidelity, or of permissible flexibility to allow 
the selection of alternative splice sites.  
The evidence that transcription rate affects splicing fidelity suggests that, at 
normal elongation rate, many splicing errors are either avoided or eliminated co-
transcriptionally. It seems less likely that transcription rate would affect post-
transcriptional degradation of mis-spliced transcripts. Indeed RP transcripts, whose 
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splicing fidelity is generally higher than for non-RP transcripts are more co-
transcriptionally spliced, and increased elongation rate strongly reduced their splicing 
fidelity. Reduction in splicing fidelity of the RP transcripts in the RNAPII fast mutant 
might be explained by a window of opportunity model, in that there is less time for the 
splicing machinery to discriminate between optimal vs suboptimal splice sites, making 
errors more likely. On the other hand, the finding that RP splicing fidelity is also 
reduced in the slow mutant, albeit less strongly (figure 5.2), cannot be so easily 
explained, and suggests that additional factors affect splicing fidelity. Similar to the 
observation with the slow mutant that showed both reduction and increase in splicing 
fidelity, it has been shown that in human cell lines, slow transcription both decreases 
or increases inclusion of a particular alternative exon, opposite to the window of 
opportunity prediction26.  These results support the idea that either splicing quality 
control mechanisms are acting differently in RPs and non-RPs or there are specific 
features controlling splicing fidelity in these genes. Similar to splicing efficiency 
(discussed in chapter 4) distinct effect of elongation rate on splicing fidelity in RP and 
non-RP transcripts indicates that transcript identity is an important factor in 
determining splicing fidelity. These results demonstrate that shorter intron length, 
lower stability of intron secondary structure and poor 3’SS score significantly correlate 
with higher SEF (figure 5.7). Furthermore, analyses show that RP transcripts with 
lower splicing fidelity in the fast and slow mutants have introns with less stable 
secondary structure (figure 5.7). Altogether, these observations suggest that offering 
more time for co-transcriptional spliceosome assembly by slowing down the 
elongation rate does not guarantee identifying and rejecting the wrong splice sites. 
Slower elongation can also expand the time window for recruitment of splicing 
suppressors or even perturb NTP-dependent kinetic proofreading mechanisms and 
eventually reduce overall splicing fidelity3,27. Additionally, changing the elongation 
rate was reported to change multiple properties of nascent RNA and the chromatin 
environment around active transcription sites, affecting alternative splicing 
decisions28–30. For example, it has been suggested that co-transcriptional pre-mRNA 
folding kinetics can be subject to modulation by transcription elongation rate7,31–33, 
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therefore it could be envisioned that increase in utilization of suboptimal splice sites 
with both faster and slower transcriptions is due to incorrect and unstable pre-mRNA 
folding. This is consistent with alternative upstream 3’SS selection upon heat shock in 
APE2, an event that creates a mRNA 18nts longer than the annotated one17. It is 
proposed that high temperature interferes with correct and stable RNA structure 
formation in the BP-3’SS region of APE2 and thereby makes alternative 3’SS more 
accessible for splicing17,34. Notably, altered elongation rates did not change use of this 
event in APE2 but use of another alternative upstream 3’SS, which creates a mRNA 
25nts longer than the annotated one increased with the fast mutant and more 
significantly with the slow mutant (figure 5.5e). Additionally, in RPS23B selection of 
an upstream 3’SS event whose use is determined by pre-mRNA folding7 increased 
significantly with the fast mutant (figure 5.5b). These observations seem to suggest 
that transcription elongation rate modulates the interplay between pre-mRNA folding 
kinetics and alternative splice sites selection such that altering transcription rate 
compromises RNA folding and correct splice sites selection. Therefore, a finely-tuned 
coordination in time and space between transcription and splicing is required to 
achieve maximum splicing fidelity. Altogether, the findings presented here strongly 
argue that pre-mRNA splicing and its coupling with transcription can play an 
important role in regulating gene expression even in a system that lacks the 
infrastructure necessary for alternative splicing. 
As discussed in chapter 4, elongation mutants also alter TSS selection. It is not 
known whether TSS usage can affect alternative splicing events, however there are 
studies showing the possible effect of promoter identity and 5’UTR structure on 
alternative splicing in human and yeast. Cramer et al demonstrated a functional link 
between promoter structure and alternative splicing of the EDI exon in the human 
fibronectin gene35. Likewise, swapping the RPL22B promoter with the GAL1 promoter 
in yeast affected splice site selection9.  Observations in chapter 4 and here indicate that 
the fast mutant not only causes stronger TSS shifts for RP intron-containing transcripts 
but also has the strongest effect on their splicing fidelity. In particular, the fast mutant 
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enhanced use of a suboptimal alternative 5’SS in RPL39 and VPS19 transcripts and 
shifted their TSS upstream compared with WT (figure 5.4). Overall, these results 
suggest that promoter identity and TSS selection likely influence co-transcriptional 
splicing fidelity, but further studies are needed to more directly investigate the effect 
of TSS selection on splicing fidelity. 
Additionally, enhanced splicing of cryptic introns residing in intron-less 
transcripts were identified with fast elongation rate (Fig. 5.6). This is presumably a 
consequence of fast transcription reducing spliceosome fidelity. Splicing of cryptic 
introns was proposed as an additional layer in dynamic regulation of gene expression 
referred to as spliceosome-mediated decay36.  When and how cells ensure controlled 
expression of each cryptic isoform in intronless genes is an interesting question for 
future investigations. An interesting example presented here is the effect of elongation 
rate on splicing of the intron in FES1 transcript. Fast elongation reduces the spliced 
isoform of the FES1 transcript, indicating that faster transcription reduces co-
transcriptional recognition/splicing of the intron at the 3’end of the FES1. However, 
slight increase of the spliced isoform with the slow mutant suggests that slower 
transcription opens the window of opportunity for recognition and splicing of the 
intron relative to WT. Reduced splicing of FES1 with the fast mutant could be due to 
ineffective recruitment of the splicing factors or cleavage and polyadenylation before 
the spliceosome completes splicing of the intron. It seems likely that incompletely 
spliced transcripts are degraded and are not spliced post-transcriptionally; otherwise, 
there should not be differences in the expression of the splice isoform between the fast 
and WT strain. However, more work is required to establish this. These results are 
compatible with observations of Gowda et al, showing that expression of the spliced 
isoform of FES1 is modulated via transcription4.  
The observation that there are hundreds of unannotated alternative splicing 
events in budding yeast suggests that the S. cerevisiae intron database is not complete 
and there are many spliced isoforms that could play important functional roles in the 
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yeast life cycle. Performing deep RNA sequencing under different physiological 
conditions could reveal more hidden alternatively spliced isoforms in intron-
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Chapter 6  Closing remarks 
Splicing is coupled to transcription machinery and occurs simultaneously with 
transcription like many other pre-mRNA processing functions. The main focus of this 
project was to investigate the importance of kinetic coupling between transcription and 
splicing for efficiency and fidelity of splicing in budding yeast (figure 6.1).  
Figure 6.1: Schematic representation of coupling between transcription and splicing. 
Various physiological stimuli such as UV light, airborne particulate matter and 
light/dark effects have been reported to affect alternative splicing by modulating 
transcription elongation rate1–3. In addition, epigenetic changes and promoter identity 
were shown to play a role in regulating alternative splicing by changing transcription 
elongation rate4–6. This study extends the evidence for functionally coupled 
transcription and splicing by demonstrating that changes in elongation rate also impact 
co-transcriptional splicing efficiency and fidelity in a gene-specific manner, providing 
a tuneable system to enhance or suppress expression of certain genes. Results show 
that fast transcription leaves splicing behind and therefore pre-mRNA accumulates 
specially for RP genes, however, slow transcription enhances co-transcriptional 
splicing transcriptome-wide. Interestingly, results showed that both fast and slow 
transcription reduce splicing fidelity mainly in RP genes (figure 6.2). The finding that 
although slower transcription increases splicing efficiency it can also reduce splicing 
fidelity, suggests that RNAPII speed may have evolved to optimise splicing efficiency 
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as well as to allow flexibility for making alternative splice site choices in yeast, as in 
mammals. Recent high-throughput studies revealed that RP transcripts tend to be 
spliced faster, more efficiently and more co-transcriptionally than non-RP 
transcripts7,8,9, and analyses presented in this thesis show that altered transcription 
rates, especially faster elongation, affect the efficiency and fidelity of splicing RP 
transcripts significantly more than non-RP transcripts. Together, these observations 
suggest that splicing of RP transcripts may be more functionally coupled to 
transcription than is splicing of non-RP transcripts, and may indicate that it is 
beneficial to splice co-transcriptionally. Ribosomal proteins are abundant and vital 
components of the translation machinery, and RP gene expression is coordinated to 
match cell growth rate according to the requirement for more or fewer ribosomes in 
rapidly or slowly dividing cells respectively10. Overall, the transcription and splicing 
of RP transcripts seem to be tuned to meet the demands of high expression without 
compromising quantity and quality of the spliced transcripts. It was previously 
proposed that there is an optimal transcription rate for splicing different introns in 
mammalian cells11. In view of the greater sensitivity of RP splicing to transcription 
speed, it can be speculated that, in budding yeast, the RNAPII elongation rate has 
evolved in tune with RP transcript splicing, to optimise the expression of these highly 
important genes, while allowing greater flexibility in splice site choice for non-RP 
genes. As the S. cerevisiae spliceosome represents an evolutionarily conserved core of 
the splicing machinery in higher eukaryotes, the effects of transcription elongation rate 
on splicing fidelity observed in yeast may be closely related to effects on alternative 
splicing decisions in higher eukaryotes. Important goals now are to determine how the 
transcription and splicing machineries communicate, and how these interactions are 
regulated to ensure the appropriate outcome.   
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Figure 6.2: Schematic representation of the co-transcriptional splicing and consequences of fast and 
slow transcription on splicing efficiency and fidelity, adapted from12. Slow transcription enhances co-
transcriptional splicing commitment and therefore increases splicing efficiency. However, fast 
transcription reduces co-transcriptional splicing commitment causing pre-mRNA accumulation due to 
reduced splicing efficiency. In the case of splicing fidelity, both fast and slow transcription reduce 
splicing fidelity (increased use of suboptimal splice sites). The effect of fast transcription in reducing 
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